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INTRODUCTION
Glutathione: Function and Biological Significance
Glutathione is a tripeptide.The structure of which
wasestablishedthroughchemicalcharacterizationand
synthesis as L-gamma-glutamyl-L-cysteinylglycine (Hopkins,
1929, Kendall et al., 1930, Harington and Mead, 1935).This
ubiquitous tripeptide has been identified in animals, plants
and many microorganisms.
In animals, glutathione is thought to be present in all
tissues at concentrations ranging from 0.5 to 12.0 mM
(Kosower and Kosower, 1978).Table 1 lists some of the
reported values for various tissues.The presence of an
atypical peptide bond between the gamma-carboxylate of the
glutamyl residue and the alpha-amino ofthe cysteinyl
residue is thought to spare glutathione from degradation by
the cellular peptidases. Protection from hydrolytic
breakdownlikelycontributestotheaccumulationof
glutathione to such high intracellular concentrations.
The term "glutathione" will be used throughout this
thesis to denote specifically the reduced form of the
tripeptide.This form accounts for the majority of the
glutathione equivalents within most cell types under normal
conditions.However, other forms may be present including
glutathione disulfide, glutathione-protein mixed disulfides,
other glutathione-mixed disulfides and thioethers (Kosower
and Kosower, 1978).2
Table 1.Tissue Levels of Glutathionea.
Tissue Concentration (mM)
Erythrocytes 2.0- 3.0
Leukocytes 3.5- 5.0
Kidney (rat) 2.5
Liver(rat) 4.5- 6.5
(mouse) 3.0
Lens 2.6- 12.0
Nervous tissue 2.0- 3.4
Stomach (rat)b 7.2- 8.2
aKosower and Kosower (1978), bBoyd et al. (1979).
The study of glutathione in the liver as a whole tissue
aswellaswithisolatedhepatocytesinvitrohave
demonstrated the existence oftwo distinct"pools"of
intracellular glutathione (Jocelyn, 1975, Meredith and Reed,
1982, Tateishi and Higashi, 1978, Wahllander et al., 1979).
The largest pool under normal conditions is the cytosolic
pool which constitutes 85-90% of the total hepatocellular
glutathione. This pool has a half-life of approximately 2.0
hours.The remaining 10-15% of the total glutathione is
found in mitochondria and has an approximate half-life of 30
hours.It is uncertain if other tissues exhibit this same
degree of glutathione compartmentalization.The half-life
of glutathione may be tissue specific.Dependent upon it's
rateofsynthesis,breakdown,utilization,uptakeand
excretion.In addition, mitochondria are thought not to
possess the enzymes necessary for glutathione synthesis.
Theyacquireglutathione viauptakefrom thecytosol
(Griffith and Meister, 1985).3
The synthesis of glutathione is thought to occur in
virtually all mammalian tissues. Glutathione is synthesized
fromit'sconstituentaminoacidsinthecytosolic
compartmentofcellsandinvolvestwoATP-dependent
enzymatic steps(see below)(Meister and Tate,1976).
gamma-Glutamylcysteine synthetase catalyzes the first step
in glutathione synthesis in which glutamic acid and cysteine
arelinked through theatypicalgamma-carbonyl-derived
peptide bond.The addition of glycine to this dipeptide is
thencarriedoutbyglutathionesynthetasetoyield
glutathione.The availability of cysteine would appear to
be the limiting factor in glutathione synthesis as the
intracellular concentration of cysteine (0.1 - 0.3 mM) is
much lower than that of the other two amino acids (Tateishi
et al., 1974).However, the availability of cysteine for
glutathione biosynthesisintheliver can begreatly
enhanced via the cystathionine pathway (Table 2) (Reed and
Beatty,1978,Reed andOrrenius,1977). Glutathione
synthesis can also be regulated by glutathione itself as it
caninhibittheactivityofgamma-glutamylcysteine
synthetase (Richman, P. andMeister, A., 1975).
gamma-glutamylcysteine synthetase
L-glutamate + L-cysteine + ATP >L-gamma-glutamyl-L-cysteine + ADP + Pi
glutathione synthetase
L -gamma -glutamyl-L-cysteine + glycine + ATP >Glutathione + ADP + PiTable2. Cystathionine Pathwaya:The Synthesis of Cysteine from
Methionine and Serine.
Step Reaction (Enzyme)
1 L-Methionine+ATP >S-Adenosyl-L-methionine +PPi + Pi
(S-Adenosylmethionine Synthetase)
2 S-Adenosylmethionine+Rb >S-Adenosylhomocysteine+CH3-R
(Methyl Transferase)
3 S-Adenosylhomocysteine >L-Homocysteine+Adenosine
(S-Adenosylhomocysteine Hydrolase)
4 L-Homocysteine+ L-Serine >L-Cystathionine
(Cystathione Synthase)
5 L-Cystathionine >L-Cysteine+alpha-Ketobutyrate+ NH4+
(gamma-Cystathionase)
aGreenberg(1975) bR= methyl group acceptor5
Numerous roles have been identified for glutathione in
animals (Table 3).It's role in cellular protection against
reactive oxygen species, radiation generated free radicals
and reactive xenobiotic metabolites are now well recognized
(Moldeus and Quanguan, 1987, Reed, 1985, Reed and Meredith,
1984, Bump and Brown, 1990).
Biotransformation denotes the enzymatic metabolism of
foreign compounds (xenobiotics) to more water soluble forms
in an effort to promote their excretion from the body.This
process has been divided into two separate parts.The first
is referred to as Phase I metabolism and involves oxidation,
reduction, or hydrolysis of the xenobiotic resulting in the
addition or unmasking of functional groups to be used in
Phase II metabolism.The principle action in Phase II
metabolism is the conjugation of the Phase I metabolites
with a water soluble moiety.A variety of different
conjugation reactions can take place depending upon the
natureofthePhaseImetabolite. Glucuronidation,
sulfation, and glutathione S-conjugation represent the major
types of conjugation reactions that characterize the Phase
II metabolic system. Glutathione isa very important
participant in Phase II metabolism of a wide variety of
xenobiotics (Chasseaud, 1979, Coles and Ketterer, 1990).
The conjugation of glutathione to xenobiotic metabolites
may be either enzymatic or nonenzymatic depending upon the
characteristicsofthemetabolite. Theenzymatic
conjugationsare carried out byafamily ofisozymes
referred to as the glutathione transferases (Boyland and
Chasseaud, 1969, Jakoby, 1978). These enzymes constitute up
to 10% and 3% of the extractable protein from rat (Jakoby
et al.,1976)or human liver (Kamisaka et al.,1975),
respectively.The isozymes have a wide range of overlappingTable3. Proposed Functions of Glutathione.
Function [Reference]
Leukotriene Biosynthesis
Leukotriene-A4 + GSHa---> Leukotriene-C4 [1]
Peroxide Metabolism H202+ 2GSH ---> 2H20 + GSSGb [2]
ROOHc+ 2GSH ----> ROHd + H2O + GSSG [ 3 ]
Free Radical Scavenger HO-+ GSH ---> H2O + GS- [4]
Storage and Transport Form for Cysteine [5]
Amino Acid Transport Across Cellular Membranes [6]
Xenobiotic Metabolism Xe + GSH ----> GSX [7]
aGSH=Glutathione,bROOH=Organic hydroperoxide,
cGSSG=Glutathione disulfide,dROH=Organic alcohol
eX=Xenobiotic
[1]= Hammarstrom et al.(1985),[2]=Cohen and Hochstein (1963),
[3]= Flohe and Gunzler (1974),[4]= Bump and Brown (1990),[5]=
Tateishi and Sakamoto(1983),[6]= Meister(1978),[7]=Chasseaud
(1979)
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substrate specificity and exhibit tissue specific isozyme
expression (Ketterer, 1986, Mannervik, 1985).Substrates
for the glutathione transferases are characteristically
hydrophobic and possess one or more electrophilic centers.
Glutathione conjugates formed in the liver may be
excreted into the plasma or bile via specific transport
processes for glutathione S-conjugates (Sies, 1988). In
either case the initial conjugation is the first step in the
formation of mercapturic acids (Tate,1980). Figure1
outlines the conversion of glutathione S-conjugates to
mercapturic acids. Thissequence ofenzymatic
transformations has become known as the mercapturic acid
pathway.
Theconjugationofglutathionetothereactive
electrophilic center of xenobiotic metabolites generated
during their metabolism would seem to serve two purposes, 1)
the removal of the chemically reactive electrophile thereby
destroyingitsabilitytoreactwithothercellular
constituentsand2)aidingintheexcretionofthe
xenobiotic via increased hydrophilicity and targeting it for
excretionasaglutathioneS-conjugate. Glutathione
conjugation hasbecome wellrecognizedasanoverall
detoxification process.
Itis true that the vast majority of glutathione
conjugations seem to result in protection of the cell and
detoxification of the xenobiotic. However,itis now
recognized that glutathione conjugation can result, either
directly or indirectly, in the production of a more toxic
substance (Anders et al., 1988,Monks et al., 1990).The
formation of a more toxic compound, which we refer to as
bioactivation,couldarisebyatleasttwo different
mechanisms.The glutathione-xenobiotic conjugate may 1)
possess a chemically reactive functional group not presentGLU-CYS-GLY
S
H
Xm
Xenobiotic
GLU-CYS-GLY
S
X
GLU
GLY
Acetyl CoA
COSH
Glutathione Transferase
*-1
gamma-Glutamyltranspeptidase
CYS-GLY
S
Dipeptidaseb
CYS
S
X
N-Acetyl-CYS
S
X
N-Acetyl Transferase
8
Figure 1.The Mercapturic Acid Pathwaya.
aTate (1980).bA variety of dipeptidases are thought to
catalyze this reaction.9
in the original xenobiotic, or 2) be a substrate for further
metabolism which results in the production ofa toxic
species.In addition, the conjugation may be reversible and
could result in concentrating the xenobiotic in specific
tissues which are more susceptible to insult following the
release of the xenobiotic from the glutathione S-conjugate.
The focus of my investigations, as delineated in this
thesis, concern the role of glutathione and glutathione
conjugation reactions in the metabolism and toxicity of 1,2-
dihaloethanes and alpha-naphthylisolthiocyanate.10
1,2-Dihaloethanes:Metabolism and Toxicity
The 1,2-dihaloethanes are a very important class of
compounds in that they have served a variety purposes in our
society,suchasseedandsoilfumigants,gasoline
additives,industrial solvents and most importantly as
starting material for vinyl halide synthesis which is used
primarily in plastics manufacture (Fishbein, 1980).Such
extensive utilization has led to an increasing concern for
the potential adverse effects that these compounds may have
on exposed individuals and our environment.Unfortunately,
the 1 , 2-dihaloethanes have become environmental contaminates
that can be found in the air and water supplies in the
United States and around the world.
1,2- Dichioroethane and 1,2-dibromoethane are produced
and used in the greatest amounts and therefore are the
predominate 1,2-dihaloethanes of concern.Both have proved
to be toxic to humans and laboratory animals (WHO, 1987,
IARC, 1977).Acute lethal oral doses of these 1,2-
dihaloethanes characteristically result in central nervous
system depression,fatty degeneration and centrolobular
necrosis in the liver and proximal tubule necrosis in the
kidneys of exposed humans and laboratory animals.
1,2-Dichloro- and 1,2-dibromoethane have also been
shown to be mutagenic in a variety of animal and bacterial
bioassays (Fabricant and Chalmers,1980, Hooper et al.,
1980) and carcinogenic in mice and rats (National Cancer
Institute,1978,Weisburger,1977). Baseduponthe
available data1,2-dichloro-and1,2-dibromoethaneare
considered to be potential human carcinogens.
Metabolism ofthe1,2-dihaloethanestochemically
reactive species is thought to be necessary for the11
development of 1,2-dihaloethane toxicity, mutagenicity and
carcinogenicity.Two principal pathways have been proposed
for 1,2-dihaloethane metabolism, mixed-function oxidation
and glutathione transferase catalyzed conjugation with
glutathione (van Bladeren et al., 1981, Guengerich et al.,
1980). Thesetwopathwaysappeartobeindirect
competition with one another and each can yield reactive
metabolites as outlined in figure 2.
The mixed-function oxidation of 1,2-dihaloethanes would
yield the respective 2-haloacetaldehyde and possibly lead to
the formation of 2-haloethanol or 2-haloacetic acid via
alcohol dehydrogenase and aldehyde dehydrogenase,
respectively (Shih and Hill, 1981, Guengerich et al., 1980).
2-Haloacetaldehydes are known to be good alkylating agents
and may contribute to the toxicity and covalent binding of
1,2-dihaloethanes to cellular macromolecules.
Direct conjugation of glutathione with 1,2-dihaloethane
is catalyzed by the glutathione transferases, a family of
isozymes with overlapping substratespecificity. The
glutathione transferases have been classified into three
classes, alpha, mu and pi (Mannervik et al., 1987).Each
enzyme consists of two subunits from within the same class
(Table 4).
Investigations with purified glutathione transferases
have shown that 1,2-dichloro- and 1,2-dibromoethane are
substrates for most of the isozymes (Cmarik et al., 1990,
Rannug et al., 1978).The product of this conjugation is a
glutathione sulfur half-mustard(Edwards etal.,1970,
Rannug et al., 1978). The sulfur half-mustard functionality
may undergo an internal cyclization characteristic of such
a functional group.Displacement of the beta halogen by the
sulfur produces a cyclic three-membered ring referred to as
an episulfonium ion (Smit et al., 1978).This three-X-CH2-CH2OH
[3]
CYTO P-450
A)X-CH2-CH2-X 00-X-CH2-CHO
[1] 02, NADPH [2]
B) CHCHX
[1]
GST
GSH
X-CH2-COOH
[4]
GS-CH2-CH2-X
[5]
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Figure 2.Principle Routes of 1,2-Dihaloethane Metabolisma.
The metabolic scheme for mixed-function oxidase(A) and
glutathione transferase (B) metabolism of 1,2-dihaloethanes
(X = Br or C1).1,2-Dihaloethane, [1]; 2-haloacetaldehyde,
[2];2-haloethanol,[3];2-haloacetic acid,[4];S-(2-
haloethyl)glutathione, [5]; glutathione transferase, (GST),
and glutathione (GSH).aAdapted from Anders and Livesey
(1980) and Guengerich et al. (1980).13
Table4. Mammalian Glutathione Transferasesa.
Species
Rat
Mouse
Homo
Cvtosolic Microsomal
Alpha Mu Pi
11 3-3 7 -7 present
1 -2 3-4
2-2 4-4
8-8 6-6
3 -?
4-4 11 3-3
2-2
cc,13,x,o,E TC present
Individual subunits are denoted by numbers.Greek
letters denote specific enzymes.aMannervik et
al.,(1987)
membered ring is a good electrophile due to the strained
nature of the ring and can be a potent alkylating agent
toward protein and nucleic acids as demonstrated for other
sulfur mustards (Brookes and Lawley, 1961, Hartwell, 1946).
The recognition that two distinct metabolic pathways
exist for 1,2-dihaloethane metabolism and that each produces
reactive metabolites has raised questions concerning the
contribution of each metabolic route in 1,2-dihaloethane
toxicity, mutagenicity and carcinogenicity.
Themutagenicityof1,2-dibromoethaneand1,2-
dichloroethane in bacterial mutagenicity assays was enhanced
by the addition of the S9 supernatant fraction of liver
homogenate (Rannug et al., 1978).Further investigations
demonstrated that the enhanced mutagenicity was dependent
upon glutathione and the 100,000g supernatant fraction14
(Rannug et al., 1978, van Bladeren et al., 1980).Rannug et
a/. (1978) also demonstrated that purified preparations of
glutathionetransferaseandglutathioneenhancedthe
mutagenicity of these 1,2-dihaloethanes. S-(2-Chloroethyl)-
glutathione,theputativemetaboliteofglutathione
transferase activation of 1,2-dichloroethane, and analogs of
this glutathione S-conjugate have been shown to be mutagenic
(Humphreysetal.,1990). Altogether,theseresults
demonstrate the importance of glutathione conjugation in the
mutagenicity of these 1,2-dihaloethanes.
1,2-Dihaloethane carcinogenicity is also thought to be
directly related to metabolism via glutathione transferase
bioactivation.Various observations have given support to
this contention.This would include the identification of
the major DNA adduct in rat liver and kidney following 1,2-
dibromoethane exposure asS-(2-(W-guanyl)ethyl)glutathione
(Koga et al., 1986, Inskeep et al., 1986).In addition,
disulfiram, a drug that reduces liver mixed-function oxidase
metabolism and increases glutathione transferase activity
was found to greatly enhance the carcinogenic potential of
1,2-dibromoethane and 1,2-dichloroethane (Plotnik et al.,
1980, Cheever et al., 1990).These data along with those
concerning mutagenicity provide support for the proposed
roleofglutathionetransferasemetabolismin1,2-
dihaloethane carcinogenicity.
The role of either metabolic pathway in the acute
toxicity of 1,2-dihaloethanes is uncertain.The liver and
kidney represent themajor target organs for toxicity and
bothpossessmixed-functionoxidaseandglutathione
transferaseactivities. Pretreatmentofanimals with
mediators of these two pathways have been shown to modulate
1,2-dihaloethane hepatotoxicity. The use of deuterated 1,2-
dibromoethane was shown to elevate serum glutamic-pyruvic15
transaminase levels in mice as compared to non-deuterated
1,2-dibromoethane (White et al.,1983).Reduced mixed-
functionoxidasemetabolismandincreasedglutathione
transferase metabolism was thought responsible for the
increased toxicity. Diethyldithiocarbamate, an inhibitor of
mixed-function oxidase activity, potentiates 1,2-
dibromoethane toxicity (Nachtomi, 1980).Disulfiram was
also shown to potentiate 1,2-dibromoethane toxicity (Wong et
al., 1982). Altogether, these data suggest that glutathione
transferase metabolism promotes 1,2-dibromoethane toxicity.
However, these observations in no way exclude the potential
contribution of mixed-function oxidase metabolism in 1,2-
dihaloethane toxicity. The role of either metabolic pathway
in 1,2-dihaloethane toxicity remains to be unequivocally
defined.
There is much interest in defining the metabolism and
mechanism of action of the 1,2-dihaloethanes.This is
primarily due to the continued use of these compounds in the
world today and recognition that they are becoming common
environmental pollutants.16
alpha-Naphthylisothiocyanate:Hepatic Injury and
Cholestasis
Cholestasis, the reduction or cessation of bile flow,
may develop in humans as a side effect of a variety of drugs
or in association with viral infections. For obvious
reasons the investigation of drug-induced cholestasis has
required the development of practical animal models that
mimic the drug-induced cholestasis observed in humans.
However, the development of cholestasis in humans as well as
in animal models is not well understood.This stems from
the lack of a complete understanding of the complexities
involved in bile formation and bile flow.Table 5 lists
potential sites for drug action that could lead to the
development of cholestasis.
One of the most widely used animal models employs
alpha-naphthylisothiocyanateasthecholestaticagent.
alpha-Naphthylisothiocyanate produces intrahepatic
cholestasis in susceptible species within 24 hours after
acuteadministration(PlaaandPriestly,1977). The
development of cholestasis is associated with
hyperbilirubinemia,elevation of serum total bile acid
content, and increased serum levels of marker enzymes of
liver injury (El-Hawari and Plaa, 1979).The principle
lesions of acute administration of alpha-naphthylisothio-
cyanate in the liver appear to involve degeneration and
necrosis of the interlobular bile ducts and focal necrosis
of hepatocytes in the portal region (Connolly et al., 1988,
Goldfarb et al., 1962).
The mechanism of alpha-naphthylisothiocyanate-induced
cholestasis is unknown.Investigations with modulators of
microsome mixed-function oxidase activity have suggested17
Table5. PotentialSitesofActioninDrug-induced
Cholestasis.
Hepatocyte
Synthesis of bile acids
Transport of bile acids across canalicular membrane
Ion transport across canalicular membrane
Tight junctional permeability
Hepatocyte viability
Bile Duct
Bile duct epithelium secretions
Bile duct permeability
Bile duct epithelium viability
that metabolism of alpha-naphthylisothiocyanate to a toxic
metabolite is responsible for its toxic effects.Phenobar-
bital and 3-methylcholanthrene pretreatment increased and
SKF 525-A,piperonyl butoxide and disulfiram decreased
alpha-naphthylisothiocyanate-induced hyperbilirubinemia, an
indirect measure of cholestasis (El-Hawari and Plaa, 1977).
However, a reactive metabolite has yet to be identified and
it's mode of action determined.It is also possible that
theinhibitorsandinducersofmixed-function oxidase
metabolism may modulate other intracellular systems that
interact with alpha-naphthylisothiocyanate to potentiate or
inhibit it's toxic effects.The modulation of glutathione
and glutathione transferase activity have been proposed as
one possibility (Dahm and Roth, 1991).
The effect of hepatic glutathione modulation on alpha-
naphthylisothiocyanate toxicity was investigated (Dahm and
Roth, 1991).The authors reported that depletion of hepatic18
glutathione gave rise to an inhibition of cholestasis and
hepatic toxicity.Further, that cholestasis developed in
concert with the repletion of tissue glutathione.These
data strongly implicate glutathione in alpha-naphthyliso-
thiocyanate-induced cholestasis and liver injury. Note that
glutathione appears to function not in protection but in
potentiating alpha-naphthylisothiocyanate toxicity.
Interest in chemically-induced toxicities involving
glutathione in a role of activation has resulted in the
investigation of alpha-naphthylisothiocyanate toxicity.In
this regardIhaveinvestigated the effect of alpha-
naphthylisothiocyanate onintracellular glutathione and
toxicity in freshly isolated rat hepatocytes.The direct
interaction of alpha-naphthylisothiocyanate with glutathione
was also studied.The results of my investigations are
presented in chapter 5 of this thesis.19
GLUTATHIONE SULFUR HALF-MUSTARDS AS ALKYLATING AGENTS'
Introduction
As with many chemical toxicants, exposure of laboratory
animals to 1,2-dihaloethanes results in the covalent binding
of1,2-dihaloethanetotissueprotein,RNAandDNA
(Arfellini et al., 1984, Hill et al., 1978, Igwe et al.,
1986, Reitz et al., 1982).The covalent binding of 1,2-
dibromoethane and 1,2-dichloroethane to protein and DNA has
beenshowntobedependentupon metabolicactivation
(Guengerich et al., 1980, Shih and Hill, 1981, Banerjee and
Van Duuren, 1979).The use of subcellular fractions in
vitro, enzyme inhibitors in vivo, and identification of the
major 1,2-dibromoethane-derived DNA adduct as a glutathione
conjugate have led to the generally accepted conclusion that
DNA alkylation results principally from the formation of
glutathione sulfur half-mustards.However, the covalent
binding 1,2-dihaloethane to proteins is not well defined
even though it accounts for the majority of the total 1,2-
dihaloethane covalently bound to cellular macromolecules
(Hill et al., 1978, Arfellini et al., 1984).
The level of 1,2-dibromoethane covalently bound to rat
liver proteins, as reported by Igwe et al. (1986), suggest
that up to 7% of the total protein of the liver may have
undergone alkylation (assuming one alkylation event per
50,000 dalton protein). However, very little is known about
'Much of this thesis chapter has been published in Chemical
Research in Toxicology, 1989, Vol 2(6), 455-460.Figures
and Tables have been reproduced with permission from the
American Chemical Society.20
the nature of the alkylating agent(s) and the specific amino
acid residues undergoing alkylation.
There are two principle metabolic routesfor the
activation of1,2-dihaloethanes,both producereactive
metabolites that could contribute to the observed covalent
binding. 2-Haloacetaldehydes,theproductof1,2-
dihaloethane mixed-function oxidation, are known alkylating
agents toward protein and nucleic acids (Banerjee et al.,
1979, Kusmierek and Singer, 1982).In contrast, little is
known about the ability of the glutathione sulfur half-
mustards, the putative 1,2-dihaloethane metabolites of the
glutathione transferase pathway,toalkylate proteins.
However, it is well established that sulfur mustards can be
active alkylating agents toward protein and DNA.Thus it is
very likely that the glutathione sulfur half-mustards are
also active alkylating agents toward both protein, RNA and
DNA.
1,2-Dihaloethane exposure may result in the in vivo
formationofglutathionesulfurhalf-mustards. 1,2-
Dibromoethane and 1,2-dichloroethane are substrates for the
glutathione transferases and the major DNA adduct identified
in 1,2-dibromoethane treated rats is apparently the result
of intracellular formation of S-(2-bromoethyl)glutathione.
Inaddition,S-(2-chloroethyl)glutathionewasrecently
identified in the bile of 1-bromo-2-chloroethane treated
rats (Marchand and Reed, 1989).This was the first direct
evidence demonstrating the in vivo formation of glutathione
sulfur half-mustards.
OurlaboratoryhassynthesizedS-(2-chloroethyl)-
glutathione and S-(2-chloroethyl)-L-cysteine, the putative
glutathione sulfur half-mustard and cysteinyl analog thought
to arise from the conjugation of glutathione with 1,2-
dichloroethane.Investigations with these compounds have21
shown that they can act as alkylating agents toward the
modelnucleophile4-(p-nitrobenzyl)pyridine(Reedand
Foureman, 1986) as well as with 2'-deoxyguanosine to yield
S-(2-(N7-guanyl)ethyl)glutathioneadduct,thesameDNA
adduct found in vivo following 1,2-dibromoethane exposure
(Foureman and Reed, 1987).In addition, these sulfur half-
mustardswerefoundtobepotentnephrotoxinswhen
administered to rats (Elfarra et al., 1985, Kramer et al.,
1987).
There are a great many questions that have yet to be
answered concerning 1,2-dihaloethane toxicity;such as the
importance of covalent binding in 1,2-dihaloethane toxicity
andtheroleofeachofthemetabolicpathwaysin
contributing to that covalent binding.The ability to
prepare S-(2-chloroethyl)glutathione and it's cysteinyl
analog and thelack ofinformation concerning protein
alkylation by specific glutathione sulfur half-mustards have
promptedmetoinvestigatefurthertheabilityof
glutathione sulfur half-mustards to function as alkylating
agents.Specifically, I have characterized the alkylation
of a variety of dipeptides, nucleosides and glutathione by
S-(2-chloroethyl)-glutathioneandS-(2-chloroethyl)-L-
cysteine. My observations andadiscussion of their
importance are presented in this chapter.22
Materials and Methods
Chemicals:
L-Cystinyl-bis-L-tyrosine, L-glycyl-L-tyrosine and L-
lysyl-L-tyrosine were obtained from Chemical Dynamics Corp.
(South Plainfield, NJ).The other dipeptides, amino acids,
nucleosidesand glutathione were purchasedfrom Sigma
Chemical Co. (St. Louis, MO).1,2-Dibromoethane, 1-bromo-2-
chloroethane, and iodo[2-14C]acetic acid (56 mCi/ mmol) were
purchased from Eastman Kodak Co. (Rochester, NY), Aldrich
ChemicalCo.(Milwaukee,WI),and Amersham(Arlington
Heights, IL), respectively.All of the chemicals used were
reagent grade or better.
PreparationofS-(2-chloroethyl)glutathioneandS-(2-
chloroethyl)glutathione:
S-(2-chloroethyl)glutathione and S-(2-chloroethyl)-L-
cysteine were synthesized as reported by Reed and Foureman
(1986).Preparative high-performance liquid chromatography
(HPLC)isolationroutinelyyieldedS-(2-chloroethyl)-
glutathione and S-(2-chloroethyl)-L-cysteine with purities
of>95%and>90%,respectively. Theimpurities
corresponding to the S-(2-hydroxyethyl)- hydrolysis products
as determined by analytical HPLC.
Extent of Dipeptide and Nucleoside Alkylation:
The extent of dipeptide and nucleoside alkylation was
investigated for reactions of 1.0 mM dipeptide or nucleoside
in 0.15 M KI121304 buffer (pH = 7.4) with 14 mM S-(2-chloro-
ethyl)glutathione or S-(2-chloroethyl)-L-cysteine added as
the dry powder.Incubation for 6 hours at 37°C was followed
by analytical HPLC analysis of the reaction mixtures23
employing mobile phases consisting of 5.0 mM KH2P0, and
methanol(1.0to60%),pH=4.6. Onemillimolar
cysteinyltyrosine was prepared by reduction of0.5 mM
cystinyl-bis-tyrosinewithdithiothreitol (DTT)for
approximately 40 minutes followed by ethylacetate extraction
to remove unreacted DTT. Reduction to cysteinyltyrosine was
showntobeessentiallycompletebyHPLCanalysis.
Dipeptideadductsweredetectedbytheirultraviolet
absorbance(UV)at 274 nm.Depending upon the parent
compound's maximum absorption,UV absorbancesforthe
nucleoside adducts ranged from 250 to 280 nm.
Reaction Rate Determination:
Reaction rates were determined with reaction mixtures
containing 4.0 mM dipeptide or nucleoside with 14 mM S-(2-
chloroethyl)glutathione or S-(2-chloroethyl)-L-cysteine in
the same manner described above.At various times aliquots
of these reaction mixtures were mixed with 100 fold excess
B-mercaptoethanol(compared toconjugate)tostop the
reaction.These B-mercaptoethanol treated fractions were
frozen with liquid nitrogen, lyophilized, and redissolved to
one-fourth the original volume with a solution containing an
internalstandard.7-Methylguanine,valyltyrosine,and
glycyltyrosine were used as internal standards for the
reaction mixtures of 2'-deoxyguanosine, cysteinyltyrosine,
andhistidyltyrosine,respectively. Inclusionofan
internal standard corrected for the day to day variability
in detector sensitivity and provided a convenient method for
determination of the amounts of adduct formed.Histidyl-
tyrosine values werecorrected tocorrespond tothat
relative to valyltyrosine to allow direct comparison with
the cysteinyltyrosine data.24
DeterminationoftheExtentandRateofGlutathione
Alkylation:
Determination of the extent and rate of alkylation of
glutathione were performed as described above except that
reaction mixtures were treated with 1-fluoro-2,4-dinitro-
benzene in the presence of excess sodium bicarbonate for 18-
24hoursandaliquotssubjectedtoHPLCanalysisas
described by Fariss and Reed(1987),utilizing gamma-
glutamylglutamate as an internal standard.
Bulk Preparation and Isolation of Adducts:
Large-scaleproductionofcysteinyltyrosineand
histidyltyrosine adducts were carried out with essentially
the same conditions as described above. Isolation and
desalting of the S-(2-chloroethyl)glutathione adducts of
cysteinyltyrosine and histidyltyrosine as well as the S-(2-
chloroethyl)-L-cysteine adduct of cysteinyltyrosine were
done with the preparative HPLC column and a methanol/water
mobile phase.Lyophilization was performed to remove the
mobile phase.The S-(2-chloroethyl)-L-cysteine adduct of
histidyltyrosine was separated from parent material on the
analytical column with a phosphate buffer/methanol mobile
phase and desalted as described.The glutathione adduct of
S-(2-chloroethyl)glutathione was prepared by mixing two
equivalents of glutathione with one equivalent of 1,2-
dibromoethanein30%ethanolinthepresenceof
triethanolamine, pH = 9.0, for 24 hours at room temperature
(Nachtomi,1970). BulkpreparationoftheS-(2-
chloroethyl)-L-cysteine adduct of glutathione was
accomplished by reacting S-(2-chloroethyl)-L-cysteine with
two equivalents of glutathione in 0.15 MKII2PO4at 37°C for
12 hours.Preparative isolation of the glutathione adducts
was performed utilizing the preparative column described25
earlier and mobile phases consisting of (4-8%) methanol,
0.1% acetic acid in water. Purity of these isolated
adducts, as judged by HPLC, was > 90%.
Adduct Analysis:
The ultraviolet spectral characteristics of the adducts
were determined for 1.0 mM solutions of purified adducts in
wateratpH6.0and12.0. Negativeionfastatom
bombardment mass spectrometry (FAB-MS) was performed by
dissolving adducts in a matrix of thioglycerol:glycerol
(2:1) and ammonium hydroxide on the probe.Proton noise
decoupled13C nuclear magnetic resonance spectroscopy (NMR)
was determined after dissolving the isolated adducts in
deuterium oxide.
Chemical Characterization of the Cysteinyltyrosine Adducts:
Iodoacetic acid binding studies were performed by first
treatingtheS-(2-chloroethyl)glutathioneandS-(2-
chloroethyl)-L-cysteine adduct of cysteinyltyrosine with DTT
(4 times excess) for 40 min at 37°C followed by extraction
with ethylacetate. Aliquots(100gl)ofthe aqueous
solution were added to 50gl ofa28 mM solution of
radiolabeled iodoacetic acid (0.37 microcuries/mmol) and
incubated at room temperature at pH = 9.0 for 1 hour in the
dark.Aliquots were analyzed by analytical HPLC, the eluate
was collected in 1-mL fractions and 0.3 ml of each fraction
were dissolved in4.0mlofformula-963 scintillation
cocktail for assay of radioactivity.
Instrumentation:
Analysis of the dipeptide and nucleoside adducts was
performed with either a LKB 2152 controller, two 2150 LC
Pumps and a Spectroflow 757 UV detector or a Kontron26
Programmer series 200, two no. 414 LC pumps and a UVikon 730
LC detector.A Hewlett Packard 3388A integrator, equipped
with two chart recorders,recorded and integrated the
signals from the detectors.Spherosorb ODSII reverse phase
columns (4.6 x 250mm, 5 micron, Custom LC, Inc., Houston,
TX) were used for the analytical applications whereas a
Partisil ODS2 reverse phase column (10 x 500mm, 10 micron,
Alltech,Deerfield,IL)wasutilizedforlarge-scale
isolations.Mobile phases were prepared from HPLC-grade
solvents and/or Milli-Q water and filtered through 0.45
micron nylon filters before use.
NMR analysis was performed with either a Bruker AM400
or AM300 NMR spectrometer operating at 400 and 300 MHz
respectively.FAB-MS (negative mode) was performed with a
KratosMS50massspectrometer. Ultravioletspectral
characterization of the dipeptide adducts was performed
utilizing a Hewlett-Packard 8452A Diode array spectro-
photometer. Ultraviolet spectra of 2'-deoxyguanosine
adducts were recorded with aLKB 2140rapid spectral
detector as they eluted from the HPLC column.Radioactivity
was measured with a Packard Tri-Carb Liquid Scintillation
Spectrometer, Model 2450.27
Results
The first phase of this investigation was concerned
with the determination of the extent of alkylation of
variousdipeptides, nucleosides and glutathione by S-(2-
chloroethyl)glutathione and S-(2-chloroethyl)-L-cysteine.
The aim was to determine which of the compounds undergo
detectable levels of alkylation and of these, which would be
best suited for further characterization and comparison. To
accomplish this I prepared 1.0 mM solutions of dipeptide,
nucleoside and glutathione in phosphate buffer and added
enough S-(2-chloroethyl)glutathione or S-(2-chloroethyl)-L-
cysteine as the dry powder to yield 14 mM sulfur half-
mustard.The mixtures were incubated for 6 hours at 37°C
and the amount of adduct present after incubation was
determined.
As is shown in table 6 all of the dipeptides gave rise
to some level of alkylation.The extent of alkylation under
these conditions exhibited the following pattern; cysteinyl-
tyrosine alkylation was >> than histidyltyrosine which was
> the other remaining dipeptides for both S-(2-chloroethyl)-
glutathione and S-(2-chloroethyl)-L-cysteine.Significant
differences between S-(2-chloroethyl)glutathione and S-(2-
chloroethyl)-L-cysteine dipeptide alkylation were observed
with lysyltyrosine, glycyltrosine and histidyltyrosine.S-
(2-chloroethyl)glutathione alkylation of glycyltyrosine gave
rise to low but detectable levels of adduct whereas S-(2-
chloroethyl)-L-cysteine did not.However, this difference
is most likely the result of the detection limit and
therefore is not likely to be of significance.
Alkylation of glutathione by both S-(2-chloroethyl)-
glutathione and S-(2-chloroethyl)-L-cysteine was extensive28
Table 6.Dipeptide and Glutathione Alkylation by S-(2-
Chloroethyl)glutathione
cysteine (CEC)a.
(CEG)andS-(2-Chloroethyl)-L-
Compound % Alkylatedb
CEG CEC
Glycyltyrosine 1.13± 0.16 <LDc
Glycyltryptophan" 1.74± 0.12 2.77± 0.36
Lysyltyrosine* 2.93± 0.15 4.27± 0.68
Histidyltyrosine" 6.86± 0.16 8.85± 0.23
Cysteinyltyrosine 87.80± 4.80d 94.50± 7.22d
Glutathione 93.00+ 2.30 91.60+ 3.90
aDipeptides or glutathione were incubated with CEG or CEC
(1:14 ratio of dipeptide:conjugate) for 6 hours at 37°C and
then analyzed by reverse-phase HPLC.Table entries are the
average of at least three separate reaction mixtures ± the
standard error. Student's paired t-test was used to
evaluate the differences in CEG vs CEC alkylations for
statisticalsignificance. b(ProductPeakArea/Total
Dipeptide Derived Area)x100%.c<LD = Below Detection Limit
(< 1 nmol / mL reaction).dDetermined as the percentage of
cysteinyltyrosine present at the start of reaction.
*CEGalkylationisstatisticallydifferentfromCEC
alkylation(P<0.05). "CEG alkylation is statistically
different from CEC alkylation (P<0.01).29
(approximately 90% alkylated).No significant difference
was observed for the extent of alkylation by S-(2-chloro-
ethyl)glutathionein comparison to S-(2-chloroethyl)-L-
cysteine.
Nucleoside alkylation was not nearly as extensive as
that for the dipeptides (Table 7).The only nucleoside to
yield detectable levels of alkylation was 2'-deoxyguanosine.
2'-Deoxyguanosine alkylation was very low (less than 2.5%
alkylated).S-(2-Chloroethyl)glutathione gave rise to a
small but significantly greater amount of adduct than S-(2-
chloroethyl)-L-cysteine.
To further the characterization of these sulfur half-
mustards, the initial rates of reaction were determined for
S-(2-chloroethyl)glutathione and S-(2-chloroethyl)-L-
cysteine with cysteinyltyrosine,glutathione,histidyl-
tyrosine and 2'-deoxyguanosine. The reaction mixtures
consisted of 4.0 mM compound and 14 mM sulfur half-mustard
in a phosphate buffer.The reaction mixtures were incubated
at 37°C and aliquots were taken and assayed.The results
are given in table 8.
Thealkylationratesofcysteinyltyrosineand
glutathione were markedly greater than that for any of the
othercompoundstested.Cysteinyltyrosinealkylation
occurred at rates 10-fold greater than histidyltyrosine and
50 times greater than 2'-deoxyguanosine for both S-(2-
chloroethyl)glutathione and S-(2-chloroethyl)-L-cysteine.
The rate of glutathione alkylation by S-(2-chloroethyl)-
glutathione was greater than that for cysteinyltyrosine
whereas S-(2-chloroethyl)-L-cysteine alkylation of
glutathione was less than that of cysteinyl-tyrosine.The
rates of glutathione, histidyltyrosine and 2'-deoxyguanosine
alkylation by S-(2-chloroethyl)glutathione was significantly30
Table7. Nucleoside Alkylation by S -(2 -Chloroethyl) -
glutathione (CEG) and S -(2 -Chloroethyl) -L -cysteine (CEC)a.
Nucleoside
CEG
% Alkylatedb
CEC
2'-Deoxyguanosine" 2.19 ± 0.26 1.45 ± 0.11
2'-Deoxyadenosine NDc ND
2'-Deoxycytidine ND ND
Thymidine ND ND
aNucleosides were incubated with CEG and CEC (1:14 ratio
nucleoside:conjugate)for6hoursat37 °C(pH=7.4)
followed by reverse-phase HPLC analysis of the mixtures.
Table entries are the average of at least three separate
reaction mixtures ± the standard error.Student's paired t-
test was used to evaluate the statistical significance of
the differences between CEG vs CEC alkylations.
b(Product Peak Area/Total Nucleoside Derived Area)x100%.
cLD = Below Detection Limit (< 1 nmol/mL reaction)
"CEGalkylationisstatisticallydifferentfromCEC
alkylation (P<0.01).31
Table 8.Initial Reaction Ratesa.
Compound
CEGb
Conjugate
CECb
Glutathione" 325.5+ 13.1 209.6+ 26.5
Cysteinyltyrosine 255.0± 20.4 268.9± 10.7
Histidyltyrosine" 16.3±2.8 26.5± 2.3
2'-Deoxyguanosine" 4.9±0.4 3.7± 0.3
°Reaction rates were determined within the first 3 minutes
ofmixing4.0mMcompoundwith14.0mMS-(2-
chloroethyl)glutathione (CEG) orS-(2-chloroethyl)-L-
cysteine (CEC) at 37°C (pH = 7.4).Reactions were stopped
with the addition of beta-mercaptoethanol.HPLC separation
allowed quantification of the amount of adduct formed.
Student's paired t-test was used to evaluate the statistical
significance between CEG and CEC alkylation rates.
"The rate of CEG alkylation was statistically different
(P<0.01) from CEC.bnmoles product formed per minute per mL
± standard error (n > 3).32
differentthanthatobservedforS-(2-chloroethyl)-L-
cysteine.
A variety of chemical and physical techniques were
utilizedtodeterminethesitesofalkylationof
glutathione, cysteinyltyrosine, histidyltyrosine and 2'-
deoxyguanosine.
Thedataconcerning2'-deoxyguanosinealkylation
suggest that alkylation occurred at the W position yielding
the respective S-(2-(W-guanyl)ethyl)-adduct as reported by
Foureman and Reed (1987).This determination was based upon
HPLC retention times and UV spectra comparisons.
The isolated adducts of cysteinyltyrosine, histidyl-
tyrosine and glutathione were subjected to FAB-MS analysis
to determine the relative molecular weights of each adduct.
In this way we could assess the degree to which the
dipeptides and glutathione were alkylated, ie. the addition
of one or more sulfur half-mustard moieties.The molecular
ions observed suggest that almost all of the adducts are the
result of a single addition of sulfur half-mustard.The
only exception to this was found for the alkylation of
cysteinyltyrosine by S-(2-chloroethyl)-L-cysteine as shown
in figure 3.Here the major molecular ion peak at 430
atomic mass units represents the addition of a single S-(2-
chloroethyl)-L-cysteine moiety.The molecular ion peak at
577 atomic mass units would represent the addition of two S-
(2-chloroethyl)-L-cysteine moieties.The nature of this
technique does not allow the determination the amounts of
mono- verses dialkylated adducts from the observed peak
intensities and so it is uncertain just what proportion of
the cysteinyltyrosine adduct is mono- verses dialkylated.
However, the data suggest that the amount of dialkylated
cysteinyltyrosine is small because of the limited amount of
adducts formed with other dipeptides such as glycyltyrosine.33
Figure 3.FAB-MS (negative ion) of the S-(2-Chloroethyl)-L-
cysteine (CEC) Adduct of Cysteinyltyrosine.Molecular ion
peaks at 430 and 577 M/Z correspond to that predicted for
the CEC monoalkylated (as shown) and dialkylated cysteinyl-
tyrosine. FAB-MSwasperformedasdescribedinthe
"Materials and Methods" section.34
The alpha-amino and tyrosyl hydroxyl groups would be the
only groups available for alkylation following cysteinyl
thiol alkylation and they have proved to not be very
reactive.
The alkylation of tyrosine residues was investigated
spectroscopically at neutral and alkaline pH's. The spectra
obtained are consistent with the notion that the tyrosyl
hydroxyl was not a site of alkylation by the sulfur half-
mustards.In addition, "C-NMR analysis of the adducts
showed no significant changes in the signals attributed to
tyrosyl carbons which would further suggest the lack of any
tyrosine alkylation events (Table 9).Acid hydrolysis of
cysteinyltyrosine and histidyltyrosine adducts followed by
HPLC analysis resulted in the release of free tyrosine from
the adducts as shown for the S-(2-chloroethyl)-L-cysteine
adduct of cysteinyltyrosine in figure 4.
The alkylation of the imidazole ring of histidyl
residues was investigated with 13C -NMR just as was done for
the tyrosyl residues.However, there were small shifts in
the carbon signals assigned to the imidazole ring.These
shifts would suggest that the adducts have a different
electronic structure than the parent histidyltyrosine. Thus
suggesting that the imidazole ring nitrogens are most likely
the site of alkylation.
The presence of free thiol within the cysteinyltyrosine
adducts was investigated with radiolabeled iodoacetic acid.
The inability of the adducts to covalently bind iodoacetic
acid suggests that the adduct does not contain a free
thiol.
Together these data suggest that the major sites for
alkylation of these dipeptides and glutathione resides with
the cysteinyl thiol and imidazole ring nitrogens and not at
the tyrosyl hydroxyl.Table 9.13C NMR Chemical Shift Data for the Tyrosyl
Ring Carbonsof Cysteinyltyrosine and Histidyltyrosine
Chemical Shifta (PPM)
and Imidazole
Adducts.
Carbon
Tyrosyl
Parent
aromatic
CTECb CTEGb HTECc HTEGc
CY 128.4 128.5 128.4
129.9 129.9 129.8
col &S2 115.8 115.8 115.8 115.7 115.7
cel&E2 130.9 130.9 131.0 130.8 130.8
C11
Histidyl
154.7
imidazole
154.9 154.9 154.4 154.5
cY 118.1 117.4 118.1
c82 129.7 129.4 127.6
Cel 135.9 134.4 134.4
1 aAcetonitrile used asreference.bCompounds dissolved in n-2- n
pH < 2.0.cCompounds dissolved in D20, pH = 7.0
HTEC =OlorE/_[2-(S-cysteinyl)ethyl]histidyltyrosine
HTEG =Olor [2-(S-cysteinyl)ethyl]histidyltyrosine
CTEC=S-[2-(cysteinyl)ethyl]cysteinyltyrosine
CTEG=S-[2-(glutathionyl)ethyl]cysteinyltyrosine36
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Figure 4.HPLC Analysis of the S-(2-Chloroethyl)-L-cysteine
(CEC) Adduct of Cysteinytyrosine (A) Beforeand After (B)
Acid Hydrolysis.Elution of (C) a tyrosine standard and (D)
a mixture of tyrosine standard and hydrolysateare given.
Chromatograms represent the elution of 274nm absorbing
material from the reverse-phase columnas described in the
"Materials and Methods" section.37
Discussion
This investigation has shown that S-(2-chloroethyl)-
glutathioneandS-(2-chloroethyl)-L-cysteine,putative
metabolites of 1,2-dichloroethane metabolism by glutathione
transferases,aredirect-acting alkylating agents. A
varietyoffunctionalgroupscommontoproteinswere
examined for their susceptibility to alkylation by these
sulfur half-mustards.The cysteinyl thiol functional group
wasshowntobethe mostactivetowardsalkylation,
exhibiting rates of alkylation more than 10-fold greater
than the next most reactive functional group.However, each
of the dipeptides examined gave rise to some level of
alkylation indicating that the sulfur half-mustards can
alkylate a variety of functional groups commonly found in
proteins.
That 2'-deoxyguanosine alkylation by these sulfur half-
mustards was greater than thatfor any ofthe other
nucleosides examined was not unexpected.Sulfur mustards,
in general, are known to react preferentially with the N7
position of guanine as compared with potential sites on
other nucleoside residues.
What was curious though was the great difference in
susceptibility between alkylation of the dipeptides verses
the nucleosides.The data suggest that protein alkylation
by the glutathione sulfur half-mustard and it's cysteinyl
analogcouldbemarkedlygreaterthanthatforDNA
alkylation in vivo.However, it must be recognized that the
availability and nucleophilicity of specific functional
groups within proteins and DNA may vary greatly from those
demonstrated with model compounds.
There is no doubt that the conjugation of 1,2-dihalo-38
ethanes to glutathione, producing the glutathione sulfur
half-mustard, is an activation step.The two sulfur half-
mustards examined were very reactive toward cysteinyl thiol,
both within the dipeptide cysteinyltyrosine as well as with
glutathione. However, this second reaction with glutathione
couldrepresentadetoxificationreactioninvivo.
Suggesting that glutathione may also function to detoxify
the sulfur half-mustards.The alkylation of glutathione
could protect other cellular constituents from alkylation.
Protection would depend upon the maintenance of sufficient
intracellular levels of glutathione.
Glutathione conjugates formed in the liver are thought
to be actively excreted either into the bile or the plasma.
In either compartment they may experience further metabolism
that could lead to the formation of mercapturic acids, the
typicalurinaryexcretionproductsofglutathioneS-
conjugates. ThistransformationfromglutathioneS-
conjugate to mercapturic acid represents the Mercapturic
Acid Pathway and results in the production of a variety of
intermediates (Figure 1).S-(2-Chloroethyl)-L-cysteine is
one of several possible intermediates that could arise
during the transformation of S-(2-chloroethyl)glutathione to
a mercapturic acid.Each of the intermediates of this
pathway possess the sulfur half-mustard functionality and
may therefore be an active alkylating agent that contributes
to the overall toxicity of the 1,2-dihaloethanes.I have
included S-(2-chloroethyl)-L-cysteineinthisstudy to
compare its activity as an alkylating agent to that of S-(2-
chloroethyl)glutathione.This characterization of S-(2-
chloroethyl)-L-cysteinemayaidinunderstandingthe
importance of glutathione sulfur half-mustard derivatives in
1,2-dihaloethane toxicity.
Small but significant differences in the extent of39
alkylation of glycyltryptophan, lysyltyrosine,
histidyltyrosine and 2'-deoxyguanosine were observed.The
extent of alkylation by S-(2-chloroethyl)-L-cysteine was
greater than that for S-(2-chloroethyl)glutathione for the
dipeptides just mentioned.The extent of 2'-deoxyguanosine
alkylation by S-(2-chloroethyl)glutathione was significantly
greater than that of S-(2-chloroethyl)-L-cysteine.These
differences in the extent of alkylation were also apparent
in the rates of reaction. Histidyltyrosine alkylation by S-
(2-chloroethyl)glutathione was 62% of that observed for S-
( 2-chloroethyl ) -L-cysteine whereas glutathione and 2 '-deoxy-
guanosine alkylation by S-(2-chloroethyl)-L-cysteine was 64%
and76%ofthatforS-(2-chloroethyl)glutathione,
respectively.The reason for these differences is not
known.
The alkylation of 2'-deoxyguanosine by S-(2-chloro-
ethyl)glutathioneandS-(2-chloroethyl)-L-cysteinewas
reported earlier (Foureman and Reed, 1987).It was observed
that S-(2-chloroethyl)-L-cysteine gave rise to detectable
amounts of adduct at lower concentrations than S-(2-chloro-
ethyl)glutathione suggesting that it is a better alkylating
agent.These data are contradictory to my observations of
2'-deoxyguanosine alkylation.It is not clear what is
responsible for the different observations.However, the
two experiments did differ in the choice of incubation
buffer and the temperature of incubation.
In addition,the interaction of S-(2- chloroethyl)-
glutathione with supercoiled plasmid DNA was drastically
different than that for the cysteinyl analog (Vadi et al.,
1985)The authors had demonstrated that S-(2-chloroethyl)-
L-cysteine induces stand relaxation indicative of single
strand breaks whereas S-(2-chloroethyl)glutathione did not.
The presence of a free alpha-amino group seemed to be40
required for plasmid relaxation.However, the mechanism
responsible for the observed differences is unknown.
The identification of S-(2-(N7-guanyl)ethyl)-
glutathione as the major DNA adduct within the liver and
kidneys of 1,2-dibromoethane exposed rats has lead to the
suggestion that glutathione sulfur half-mustards play an
important role in the carcinogenic potential of the 1,2-
dihaloethanes. However,littleisknownaboutthe
relationship between the formation of glutathione sulfur
half-mustards in vivo, the extent to which these contribute
to the total covalent binding to protein and the toxicity
that occurs within the liver and kidneys of exposed animals.
It was because of this lack of information that this
investigation was initiated.The emphasis was to provide a
foundation for future investigations to better define the
role of glutathione sulfur half-mustardsinthe above
relationships. In this regard, I have demonstrated that
cysteinyl thiol groups are particularly good targets for S-
(2-chloroethyl)glutathione and S-(2-chloroethyl)-L-cysteine
alkylation.That other amino acid functional groups are
also good targets and that those nucleosides common to DNA
do not possess an inherent reactivity which would promote
theiralkylationoveraminoacidresidues. This
characterization of S-(2-chloroethyl)glutathione and it's
cysteinyl analog as alkylating agents should benefit future
investigations of 1,2-dihaloethane bioactivation and aid in
understanding its relationship to toxicity.41
1,2-DIHALOETHANE METABOLISM AND GLUTATHIONE DEPLETION IN
FRESHLY ISOLATED HEPATOCYTES.
Introduction
Two distinct metabolic pathways have been proposed as
the major routes for 1,2-dihaloethane metabolism in animals
(van Bladeren et al., 1981, Guengerich et al., 1980).Each
of these pathways can give rise to chemically reactive
metabolites and their characterization as alkylating agents
has been discussed in the previous chapters.Tissues, such
as the liver and kidney, contain substantial amounts of the
enzymes responsible for each of the two metabolic pathways.
Inthisregard,theyrepresent majorsitesfor1,2-
dihaloethane metabolism.In addition, the liver and kidneys
have been identified as the major target organs for 1,2-
dihaloethanetoxicity. Thecovalent bindingof1,2-
dihaloethane in these tissues has been shown to be greater
than that for other non-target tissues (Arfellini et al.,
1984, Hill et al., 1978, Igwe et al., 1986, Reitz et al.,
1982).All together these observations suggest a link
between metabolism and toxicity.
Glutathione depletion in these tissues is a common
characteristic of 1,2-dihaloethane exposure (D'Souza et al.,
1988, Mann and Darby, 1985).The depletion of glutathione
would seem to complement the finding of large quantities of
1,2-dihaloethane-derived mercapturic acids and other sulfur
containing metabolites in the urine of 1,2-dihaloethane-
treated animals (Reitz et al.,1982,Yllner,1971, van
Bladeren et al., 1981, Goyal et al., 1989).Presumably each
of the urinary products represents the interaction of 1,2-42
dihaloethane or a reactive metabolite of 1,2-dihaloethane
with glutathione.
The depletion of glutathione from these tissues may be
the result of both mixed-function oxidation and glutathione
transferase conjugation pathways. Mixed-function oxidation
of the 1,2-dihaloethanes produces 2-haloacetaldehydes which
may undergo further metabolism to 2-haloethanol and 2-
haloacetic acid.The 2-haloacetaldehydes are known to be
active alkylating agents toward protein and DNA and may also
contribute to glutathione depletion.In addition, direct
conjugationof1,2-dihaloethanestoglutathione,as
catalyzed by the glutathione transferases, may contribute
both directly and indirectly to glutathione depletion.The
S-(2-haloethyl)glutathioneproducedmayreactwithan
additional molecule of glutathione.Figure 5 represents
potential sites for the consumption of cellular glutathione
in 1,2-dihaloethane metabolism.However, the contributions
of either metabolic pathway to the depletion of glutathione
and the effect of this on toxicity is yet undefined.
In an effort to further our understanding of the role
ofglutathionein1,2-dihaloethane metabolism wehave
investigated the metabolism of three 1,2-dihaloethanes in
freshly isolated hepatocytes.Our particular aim was to
characterize changes in intracellular glutathione and to
relate these changes to specific routes of metabolism.GSH
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Figure 5.Potential Utilization of Glutathione in 1,2-Dihaloethane
Metabolism.X = Br or Cl, GSH = glutathione.44
Materials and Methods
Chemicals:
Glutathione, gamma-glutamylglutamate, glutathione
disulfide, and 1,2-dibromoethane-1,2-14C (13.3 mCi/mmol) were
purchased from Sigma Chemical Company (St. Louis, MO).1,2-
Dichloroethane, 1-Bromo-2-chloroethane, iodoacetamide, 2-
chloroethanol, 2-chloroacetic acid and 2-chloroacetaldehyde
were purchased form AldrichChemical Company (Milwaukee,
WI).1,2-Dibromoethane was purchased form Eastman Kodak Co.
(Rochester, NY).
Isolation of Hepatocytes:
Hepatocytes were isolated from male Sprague-Dawley rats
(180-210gm)asdescribedbyFarissetal.(1985).
Hepatocyte viability was greater than 90% as assessed by
trypan blue exclusion directly after isolation.
IncubationofHepatocyteswith1,2-Dihaloethanesand
Chlorinated Derivatives:
Freshly isolated hepatocytes were resuspended to a
concentration of 2.0 x106 cells per ml in a modified
Fischer's medium which lacked all sulfur amino acids except
for methionine (0.67 mM) and contained 3.5 mM calcium, 10 mM
4-((2-hydroxyethyl)-1-piperazine)ethanesulfonic acid,and
20-60 mM gamma-glutamylglutamate as an internal standard for
HPLC analysis.Ten milliliters of cell suspension was
placed into 25 ml Erlenmeyer flasks and an aliquot of agent
added.The 1,2-dihaloethanes were added directly to the
flasks whereas the chlorinated derivatives were prepared in
water just prior to addition.The flasks were sealed with
rubber septums and incubated at 37°C for one hour in an45
orbital shaker.After incubation, aliquots of the cell
suspension were taken and prepared for high performance
liquid chromatography (HPLC) analysis.
Studies with the radiolabeled 1,2-dibromoethane were
conducted as described above for the nonradiolabeled 1,2-
dihaloethanes. However,theeluentfromtheHPLC
ultraviolet detector was collected in one minute fractions
and mixed with Formula 969 scintillation cocktail(NEN
Research Products, Boston, Mass.).The radioactivity was
measured withaPackard Tri-Carbliquidscintillation
spectrometer. The quenching of samples was considerable and
required that each vial be counted twice, before and after
spiking with 14C-toluene.
Lactatedehydrogenaseleakagewasdeterminedas
described by Fariss et al.(1985) except that a Kontron
spectrophotometer (UVikon 810) was used in place of the
Beckman Enzyme Activity Analyzer.
HPLC Analysis:
To quantitate the formation of glutathione-containing
metabolites, 0.6 ml of cell suspension was added to 0.1 ml
70% perchloric acid (PCA) in 1.5 ml microfuge tubes.After
vortexing and centrifugation (13000 x g for one minute) an
aliquot of the supernatant was derivatized with Sanger's
reagent as described (Fariss and Reed, 1987) except that
iodoacetamide was substituted for iodoacetic acid.
Determinationofintracellularglutathionewas
performed as described by Fariss and Reed (1987) with the
noted exception.Briefly, 0.6 ml of cell suspension was
placed over 0.4 ml of dibutylphthalate that was layered over
0.5 ml 10% PCA containing 20 nmoles gamma-glutamylglutamate.
Centrifugation for one minute at 13000 x g was used to
pellet "viable" cells through the oil layer and into the46
PCA.Aliquots of the PCA supernatant were assayed as above.
HPLC employed anion exchange columns prepared from 3-
aminopropylsilane-derivatized Spherisorb, a binary mobile
phase system consisting of 80% methanol and 0.8 M acetate in
80% methanol as described (Jean and Reed, 1989).Note that
longer columns (4.6 mm x 300 mm) and a variety of gradient
programs were used to aid in the resolution of components.
Standards of the compounds of interest were derivatized as
abovefor the cellsamplesand their retention times
characterized with each column/gradient system just prior to
analysis of cell samples.A SpectraPhysics HPLC pump and
SP8700XR pump controller, Micrometrics autosampler model
#728,Spectroflow 757 UV detector and Hewlett Packard
integrator model 3390A were used.
Chemical Synthesis:
The synthesis of S-(2-hydroxyethyl)glutathione was
carried out by adding excess 1-bromoethanol to glutathione
under alkaline conditions. Isolation of S-(2-hydroxyethyl)-
glutathione from the reaction mixture was performed by
preparative HPLC using a reverse phase C18 column (Whatman
ODSII, 20mm x 500mm) and 0.1% acetic acid as the mobile
phase.S-(2-Hydroxyethyl)glutathione was collected upon
elutionfromthecolumn,frozen,lyophilizedand
characterized by Fast Atom Bombardment mass spectrometry.
Purity was judged to be better than 97% by HPLC with the
major contaminate being glutathione.
S,S--(1,2-Ethanediy1)-bis[glutathione] was formed by
mixing two equivalences of glutathione with one equivalent
of 1,2-dibromoethane in 30% ethanol in the presence of
triethanolamine, pH = 9.0 at room temperature for 24 hours
(Nachtomi, 1970).Isolation and characterization of S,S--
(1,2-ethanediyl)bis[glutathione] from the reaction mixtures47
was performed as above with the exception of using 10%
methanol, 0.1% acetic acid as the mobile phase.
S-Carboxymethyl-glutathionewasisolatedfromthe
reaction mixture in which 100 mg of glutathione was added to
120 mg iodoacetic acid in 5.0 ml 0.5 M Tris-base at pH =
9.1.Preparative HPLC was used to purify the S-carboxy-
methyl-glutathioneas was doneforS-(2-hydroxyethyl)-
glutathione.
Glutathione reacts readily with 2-chloroacetaldehyde to
form S-formylmethyl-glutathione (Johnson, 1967).However,
theisolationofS-formylmethyl-glutathionefromits
reaction mixture was unsuccessful.Our attempts to isolate
S-formylmethyl-glutathione from reactions mixtures were also
unsuccessful.48
Results
Exposure of freshly isolated hepatocytes to 1.2 mM 1,2-
dichloroethane, 1-bromo-2-chloroethane, or 1 , 2-dibromoethane
gave rise to various levels of glutathione depletion by one
hour (Figure 6). The 1,2-dihaloethane-induced loss of
intracellular glutathione was greatest for 1 , 2-dibromoethane
(83%depletion)andleastfor1,2-dichloroethane(19%
depletion).The loss of glutathione from these cells was
not due to cell lysis as suggested by the lack of lactate
dehydrogenase leakage from treated cells (data not shown).
Exposure of freshly isolated hepatocytes to radio-
labeled 1,2-dibromoethane gave rise to the formation of at
least three metabolites with retention times characteristic
ofS-(2-hydroxyethyl)glutathione,S-carboxymethyl-gluta-
thione and S,S--(1,2-ethanediy1)bis[glutathione] (Figure 7) .
The amount of each metabolite formed for the different
1,2-dihaloethanes varied asshown in figure8. 1,2-
Dibromoethane and 1-bromo-2-chloroethane gave rise to large
amounts of S-(2-hydroxyethyl)-glutathione. The amount of S-
carboxymethyl-glutathione was very low for all three of the
1,2-dihaloethaneswhereastheamountofS,S--(1,2-
ethanediy1)bis[glutathione] varied.As with the depletion
ofglutathione,thelevelofS,S--(1,2-ethanediy1)bis-
[glutathione]formed wasdirectly proportionaltothe
bromine content, ie. the greater the bromine content the
greater the amount of S,S --(1,2-ethanediy1)bis-[glutathione]
formed.
There whereatotaloffivedifferentformsof
glutathione measured in this study, glutathione, glutathione
disulfide, S-(2-hydroxyethyl)glutathione, S-carboxymethyl-
glutathione and S,S'-(1,2-ethanediy1)bis[glutathione]. The80
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Figure 6.1,2-Dihaloethane-induced Depletion of Glutathione
in Isolated Rat Hepatocytes.Hepatocytes (2.0 x 106 cells
per ml) were treated with 1,2-dihaloethane for one hour and
the amount ofglutathione remaining was determined as
described in the "Materials and Methods" section.Values
represent the mean of at least three to five experiments +
SEM.(*) denotes significantly different from control (p <
0.01). DCE=1,2-dichloroethane,BCE=1-bromo-2-
chloroethane and DBE = 1,2-dibromoethane.1.00 -
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Figure 7. HPLCAnalysisofGlutathione-containing
Metabolites from 1,2-Dibromo-[l,2-14C]-ethane Treated Rat
Hepatocytes.The upper chromatogram represents the elution
of 365 nm absorbing material and the lower chromatogram
radioactivity. Freshly isolated hepatocytes were treated and
assayed as described in the "Materials and Methods" section.
Peak assignments are based upon the elution times of
standards. HEG = S-(2-hydroxy-ethyl)glutathione, CMG = S-2-
carboxymethyl-glutathione, and GEG = S,S'-(ethanediyl)bis-
[glutathione].r-I
r-I
a)
0
E
a)
s-i
a
a)
0
E
51
20
10_
0
HEG CMG
Metabolite
DCE
BCE
0DBE
**
GEG
Figure 8. QuantitationofGlutathione-containing
Metabolites from 1,2-Dihaloethane Treated Rat Hepatocytes.
Freshly isolated hepatocytes were treated with 1.2 mM 1,2-
dihaloethane for one hour as described in the "Materials and
Methods" section.Values represent the mean of at least
five separate experiments ± SE.(*) Significantly different
from DCE (p< 0.01) and (**) significantly differentthan
DCE and BCE (p< 0.05).DCE = 1,2-dichloroethane, BCE = 1-
bromo-2-chloroethane, DBE = 1,2-dibromoethane, HEG = S-(2-
hydroxyethyl)-glutathione,CMG=S-carboxymethyl-gluta-
thione, GEG = S,S--(1,2-ethanediy1)bis[glutathione].52
levels of each are depicted in figure 9 as theequivalents
of glutathione found in each.These data demonstrate that
55% or more of the depleted glutathione could beaccounted
for in the formation of the threeglutathione-containing
metabolites.The only significant loss of glutathione that
could not be accounted for occurred with1,2-dibromoethane.
Approximately 20% of the glutathione loss could not be
accounted for, an observation that led to theexamination of
1,2-dibromoethane covalent binding.
In addition to glutathione depletion,1,2-dibromoethane
became covalently bound to hepatocellularprotein (Table
10). The rate of 1,2-dibromo-[1,2-14C]-ethane covalent
binding decreased with the time of incubation and correlated
with glutathione depletion.After 2 hours of incubation, a
total of 18.7 nmoles of 1,2-dibromo-[12-14C]-ethane was
covalently bound per ml cell suspension. Half of this total
occurred within the first 30 minutes ofincubation (9.6
nmoles per ml cell suspension).Intracellular glutathione
remained relatively high during this same periodremaining
above 30% of initiallevels.By 60 minutes of incubation,
77% of the total covalent binding occurred underconditions
of glutathione depletion to only 17% ofinitial levels.The
second hour of incubation gave rise to almostcomplete
depletion of intracellular glutathione accompanied by an
additional amount of covalent binding of only 4.3 nmoles per
ml cell suspension.
In an effort to understand how themixed-function
oxidasemetabolitesmaycontributetothelossof
glutathioneandtheformationoftheseglutathione-
containing metabolites, freshly isolated hepatocytes were
treated with 2-chloroacetaldehyde, 2-chloroethanol and 2-
chloroaceticacid. TheamountofS-(2-hydroxyethyl)-
glutathione, S-carboxymethyl-glutathione and S,S'-(1,2-C DCE BCE
1.2 mM
1,2-Dihaloethane
DBE
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Figure9. Accountabilityof1,2-Dihaloethane-induced
Depletion of Glutathione. The quantity of glutathione
recoveredasglutathione(GSH),glutathionedisulfide
(GSSG),S-(2-hydroxyethyl)glutathione(HEG),S-carboxy-
methyl-glutathione(CMG),and S,S"-(ethandiyl)bis[gluta-
thione](GEG) following 1 hour of incubation with 1.2 mM
1,2-dihaloethane.Data are expressed as the percent of
glutathione equivalences for control.Values represent the
mean (+SEM) of at least three separate experiments."*"
denotes "significantly different than control" (p < 0.05).
C = control, DCE = 1,2-dichloroethane, BCE = 1-bromo-2-
chloroethane, DBE = 1,2-dibromoethane.
GSH (01),GSSG (ED, HEG ),CMG (0, ),GEG ([3)Table10. Time-dependent Accumulation of Glutathione-containing
Metabolites and Covalent Binding During 1,2-Dibromo-[1,2-14C]-ethane
Metabolism by Isolated RatHepatocytes.
Control Treated
Protein
Covalent
Time GSH HEG CMG GEG Bindincra Total
[minutes] [nmolesGSH equivalence perml cellsuspension(+SE)]
0 45.2 45.2 0.0 0.0 0.0 0.0 45.2
(8.1) (8.1)
15 47.3 30.6 4.9 3.5 10.6 5.3 54.9 (7.6) (3.2) (0.7) (3.5) (3.9) (0.6)
30 52.8 15.2 9.2 6.2 14.6 9.6 54.8
(8.8) (3.5) (1.4) (0.9) (3.7) (0.7)
60 65.5 8.1 14.1 8.3 16.4 14.4 61.3
(9.8) (1.2) (2.2) (1.6) (5.9) (0.8)
120 104.1 3.2 8.4 11.1 21.2 18.7 83.3
(20.2) (3.9) (2.9) (7.4) (7.0) (1.8)
These data representatleast threeseparate experiments.a nmolesofcovalently
bound 1,2-dibromoethane per ml cellsuspension based upon an estimated 2.4mg
protein per ml cell suspension(2.0x 106 cells per ml).GSH =glutathione, HEG
S-(2-hydroxyethyl)glutathione,CMG=S-2-carboxymethyl-glutathione,GEG=S,S'-
(1,2-ethanediy1)bis-(glutathione].55
ethanediyl)bis[glutathione]were determined(Table11).
None of these compounds gave rise to the formation of S,S'-
ethylene-bis-glutathione.2-Chloroacetic acid gave rise
solelytoS-carboxymethyl-glutathionewhereas 2-
chloroethanol produced principally S-carboxymethyl-
glutathione(93%)andonlyasmallamountofS-(2-
hydroxyethyl)glutathione (7%). 2-Chloroacetaldehyde
produced both S-(2-hydroxyethyl)glutathione (44%) and S-
carboxymethyl-glutathione (56%).
1,2-Dihaloethane incubations were also performed under
conditions of high extracellular glutathione (1.0 mM) to
determine the extent to which glutathione sulfur half-
mustards exit the cells.The presence of extracellular
glutathione was found to increase the amount of S,S.-(1,2-
ethanediy1)bis[glutathione] by 120, 179 and 161% following
incubation with 1,2-dichloroethane, 1-bromo-2-chloroethane
and 1,2-dibromoethane, respectively (Table 12).The effect
of extracellular glutathione on S-(2-hydroxyethyl)gluta-
thionewaslessdramaticandvariedwiththe1,2-
dihaloethane.
S-Carboxymethyl-glutathione formation was not altered
by the presence of extracellular glutathione.56
Table 11.Metabolism of 1,2-Dichloroethane Derivatives to
Glutathione-containing Metabolites.
Agent HEG CMG GEG
(nmoles per ml cell suspension ± SE)
2-chloroacetic acid ND 49.0± 6.9 ND
2-chloroethanol 3.1 ± 1.0 35.8± 3.0 ND
2-chloroacetaldehyde23.0 ± 2.6 29.2± 2.8 ND
Freshly isolated hepatocytes were treated with 2-chloro-
ethanol(0.5 mM),2-chloroacetic acid (0.5 mM),and 2-
chloroacetaldehyde (0.25 mM) for 1 hour, and the amount of
glutathione-containingmetabolitespresentdetermined.
Values represent the mean ± SE for at least three separate
experiments. "ND"= formationof metabolite was not
detected.
HEG = S-(2-hydroxyethyl)glutathione
CMG = S-carboxymethyl-glutathione
GEG = S,S--(1,2-ethandiy1)bis(glutathione)57
Table 12.Effect of Extracellular Glutathione (1.0 mM) on
the Formation of S,S--(1,2-Ethanediy1)bis[glutathione].
Agent GEG
(% of Control ± SE)
1,2-dichloroethane 120.5± 22.4
1-bromo-2-chloroethane 179.3*+ 14.1
1,2-dibromoethane 161.4*± 12.3
Freshly isolated hepatocytes were treated with 1.2 mM 1,2-
dihaloethane in the presence or absence (control) of 1.0 mM
glutathioneand the quantity ofS,S--(1,2-ethanediy1)-
bis[glutathione] (GEG) determined. The values represent the
effective change in metabolite formation by the inclusion of
extracellular glutathione.The values represent the mean ±
SE for at least three separate experiments. (*) The amount
of metabolite formed with the addition of extracellular
glutathione was significantly different (p < 0.05) than
control.58
Discussion
This investigation has demonstrated that exposure of
freshly isolated hepatocytes to any one of three 1,2-
dihaloethanesresultsinthelossofintracellular
glutathione with the concomitant production of at least
three glutathione-containing metabolites.The ability of
these 1,2-dihaloethanes to reduce intracellular glutathione
in this model system is characteristic of these same agents
in vivo (D'Souza et al., 1988, Mann and Darby, 1985).
As depictedinfigure2,the metabolism of1,2-
dihaloethanes to reactive species could occur through two
different pathways.Glutathione, as the major nonprotein
thiol in these cells, could potentially participate in 1,2-
dihaloethane metabolism in a variety of ways as outlined in
figure 5.Our investigation has shown that S-(2-hydroxy-
ethyl)glutathione,S-carboxymethyl-glutathione and S,S'-
(1,2-ethanediy1)bis[glutathione]areproducedfollowing
exposure of freshly isolated hepatocytes to 1,2-dichloro-
ethane,1-bromo-2-chloroethaneand1,2-dibromoethane.
Presently there remains considerable uncertainty as to the
contributions of either pathway in the production of S-(2-
hydroxyethyl)-glutathione and S-carboxymethyl-glutathione.
Both could be produced from either the mixed-function
oxidase or the glutathione transferase pathway.However,
S,S--(1,2-ethanediy1)bis[glutathione] formation is thought
to originate solely from the glutathione S-transferase
pathway.
The metabolism ofvarious putative mixed-function
oxidase metabolites of 1,2-dichloroethane was studied in an
effort to determine their ability to produce the same
glutathione-containing metabolites as was formed with the59
1 , 2-dihaloethanes .2-Chloroacetaldehyde gave rise to almost
equalamountsofS-(2-hydroxyethyl)glutathioneandS-
carboxymethyl-glutathione. Given that 2-chloroacetaldehyde
reacts rapidly with glutathione.in vitro (Johnson, 1965) it
is assumed that upon entering the hepatocytes it would
quickly react with intracellular glutathione to form S-
formylmethyl-glutathione. Attemptstopurifyand
characterize S-formylmethyl-glutathione were unsuccessful as
it appears that this compound is not stable under the
conditions usedfor HPLC derivatization andanalysis.
Nonetheless, the possibility remains that the intracellular
formation of S-formylmethyl-glutathione may result in the
formation of S-carboxymethyl-glutathione or S-(2-hydroxy-
ethyl)glutathioneviafurtheroxidationorreduction,
respectively.
The data obtained suggest that both conversions are
possibleandthatneitherisfavoredovertheother
resulting in almost equal amounts of S-(2-hydroxyethyl)-
glutathioneandS-carboxymethyl-glutathioneformation.
These data suggest that 2-chloroethanol, which gave rise
primarily to S-carboxymethyl-glutathione, was oxidized to
thecarboxylicacidpriortoitsconjugationwith
glutathione. TheamountofS,S
.
-(1,2-ethanediy1)bis-
[glutathione] formed from the 1,2-dihaloethanes may be taken
as an indirect measure of sulfur half-mustard formation
within the hepatocytes.This would be an estimate of the
lowest level of mustard formation because alkylation of
glutathione is but one of the various reactions that the
sulfur half-mustards may undergo.The sulfur half-mustards
are known to be unstable, giving rise to S-(2-hydroxyethyl)-
glutathione as well as to react with protein and nucleic
acids.Thus, it is possible that hydrolysis of the sulfur
half-mustards could be responsible for a large proportion of60
the total S-(2-hydroxyethyl)glutathione formed in these
experiments.This would seem to be the true based upon the
observationsrelatedtothemetabolismof2-chloro-
acetaldehyde. S-(2-hydroxyethyl)glutathione formation from
1,2-dihaloethane mixed-function oxidation should be no
greater thantheamountofS-carboxymethyl-glutathione
formation. TheamountofS-carboxymethyl-glutathione
formation was very low for all of the 1,2-dihaloethane
exposures.This would suggest that the majority of the S-
(2-hydroxyethyl)glutathioneproducedbeduetothe
hydrolysis of the respective S-(2-haloethyl)glutathione.
Therefore, hepatocytes may be exposed to a substantial
amount of sulfur half-mustards, particularly in the case of
1,2-dibromoethane and 1-bromo-2-chloroethane.Apparently
the glutathione transferase pathway is responsible for the
majorityofthe1,2-dihaloethane-inducedglutathione
depletion.
The ability of hepatocytes to export of glutathione and
various glutathione S-conjugates is well known (Sies, 1983,
Ormstad and Orrenius, 1983).The mutagenicity of bile from
1,2-dichloroethane-treated rats has been attributed to the
hepatocellular excretion of S-(2-chloroethyl)glutathione
into the bile (Rannug and Beije, 1979).More recently, S-
(2-chloroethyl)glutathione has been identified in the bile
of1-bromo-2-chloroethane(MarchandandReed,1989).
Altogether,these dataindicate that1,2-dihaloethane-
treated hepatocytes may potentially excrete S-(2-haloethyl)-
glutathione during 1,2-dihaloethane metabolism.To assess
this possibility, the effect of extracellular glutathione on
theformationofS,S--(1,2-ethanediy1)bis[glutathione)
following 1,2-dihaloethane exposure was examined.
Extracellularglutathionewasfoundtosignificantly
increase the formation of S,S--(1,2-ethanediy1)bis-61
[glutathione] from1-bromo-2-chloroethaneand 1,2-
dibromoethane.These findings are in agreement with the
proposed ability of hepatocytes to excrete the glutathione
sulfur half-mustards.
It is apparent from the metabolism studies that not all
of the glutathione depletion could be accounted for with the
formation of the three glutathione-containing metabolites.
This was especially true for 1,2-dibromoethane in which
approximately21.4nmolesofglutathionepermlcell
suspension could not be accounted for following 1 hour of
incubation.The relative amounts of glutathione-containing
metabolitesformedandtheinvestigationswith2-
chloroacetaldehyde strongly suggest that the glutathione
transferase catalyzed conjugation of 1,2-dibromoethane with
glutathione,toformS-(2-bromoethyl)glutathione,was
responsible for the majority of the glutathione depletion
and metabolite formation.Therefore, it is possible that
the loss of glutathione may be due to the alkylation of
cellular macromolecules by S-(2-bromoethyl)glutathione.To
investigate this further, hepatocytes were treated with 1,2-
dibromo-[1,2-"C]-ethane and the amount of 1,2-dibromo-[1,2-
"C]-ethanecovalentlyboundtohepatocyteprotein
determined. Thegreatestextentofcovalent binding
occurred under conditions of high intracellular glutathione.
In terms of accountability, the total amount of glutathione
present as glutathione and glutathione-containing
metabolites when added to the amount of covalent binding,
agreeswellwiththetotalamountofglutathionein
controls.These data suggest an interesting relationship
between the formation of glutathione sulfur half-mustards
andcovalentbindingthatmaybeimportantto1,2-
dihaloethane toxicity.
Overall this investigation has shown that freshly62
isolated hepatocytes are susceptible to 1,2-dihaloethane-
induced glutathione depletion as is characteristic of the
liver in 1,2-dihaloethane-treated animals.The majority of
the glutathione depletion can be accounted for in the
formation of three glutathione-containing metabolites.In
addition,thesedatasuggestthattheglutathione
transferase catalyzed conjugation of 1,2-dihaloethanes to
glutathioneisresponsibleforthemajorityofthe
glutathione depletion.This would represent the formation
of substantial amounts of glutathione sulfur half-mustards.
However, the importance of the glutathione sulfur half-
mustard formation in 1,2-dihaloethane-induced toxicity has
yet to be clearly defined.63
1,2-DIBRONOETHANE-INDUCED TOXICITY IN FRESHLY ISOLATED RAT
HEPATOCYTES
Introduction
1,2-Dihaloethanes are widely used in the world today
and have become environmental contaminants of some concern.
They are mutagenic (Fabricant and Chalmers, 1980, Hooper et
al., 1980), carcinogenic in laboratory animals (NCI, 1978,
Weisburger, 1977) and toxic to humans and laboratory animals
(WHO, 1987, van Bladeren et al., 1981, Guengerich et al.,
1980).The available data strongly implicate metabolism in
the mutagenicity and carcinogenicity of these compounds
(Rannug et al., 1978, van Bladeren et al., 1980,Rannug,
1980). Specifically,metabolism involving glutathione
conjugation and the formation of reactive sulfur half-
mustards.
Glutathione sulfur half-mustards are unique in that
they denote the unusual participation of glutathione in
xenobiotic bioactivation.The glutathione sulfur half-
mustard, S-(2-chloroethyl)glutathione, has been shown to be
a direct-acting alkylating agent (Jean and Reed, 1989)and
recent studies have demonstrated its formation in vivo
(Marchand and Reed, 1989). S-(2-Chloroethyl)glutathione and
its derivatives have been shown to be mutagenic (Humphreys
etal.,1990). In addition, S-(2-(N7-guanyl)ethyl)-
glutathione was identified as the major DNA adduct in rat
liver and kidney following 1,2-dibromoethane exposure (Koga
et al., 1986, Inskeep et al., 1986).
1,2-Dihaloethane exposures of laboratory animals and
humans have demonstrated a variety of effects concerning64
central nervous system depression and injury to the exposed
tissues and internal organs (WHO, 1987, Alexeeff et al.,
1990). The major target organs of 1,2-dihaloethane toxicity
havebeenidentifiedastheliverandkidney. The
mechanism(s) responsible for the target organ toxicities
have not been defined. Difficulties with assessing toxicity
in in vivo systems coupled with the presence of two distinct
metabolic pathways for 1,2-dihaloethane metabolism, both of
which produce reactive metabolites, have greatly limited
progress towards elucidation of the mechanisms involved.
Investigations in vivo have demonstrated that the liver
of 1,2-dihaloethane exposed animals undergoes a dramatic
loss of glutathione shortly after exposure (Botti et al.,
1982,Johnson,1965). That covalent binding of1,2-
dihaloethane to protein, RNA and DNA in the liver and kidney
is greater than that for any of the other tissues studied
(Arfellini et al., 1984, Reitz et al., 1982, Hill et al.,
1978). In addition, a variety of urinary metabolites have
been identified (WHO, 1987, van Bladeren et al., 1981), most
containing sulfur thought to be derived from glutathione.
Prior studies from our laboratory have demonstrated
that isolated hepatocytes metabolize 1,2-dichloroethane, 1-
bromo-2-chloroethane and 1 , 2-dibromoethane to at least three
glutathione-containing metabolites (Jean and Reed, 199X).
These metabolites could not accountfor the whole of
glutathione depletion with the greatest deficit occurring
for 1,2-dibromoethane.The amount of covalent binding of
1,2-dibromoethane to cellular protein was also studied and
foundtobeinclose agreement with thatamountof
glutathione unaccounted for. These data, together with what
is known of the reactivity of glutathione sulfur half-
mustards and of their potential for formation, strongly
suggest that the covalent binding of 1,2-dibromoethane to65
hepatocellular protein was the result of S-(2-bromoethyl)-
glutathione formation.
However, the importance of glutathione sulfur half-
mustard formation in 1 , 2-dihaloethane-induced hepatotoxicity
is yet uncertain.Conjugation of glutathione with 1,2-
dihaloethanes would seem to promote a hazardous situation
forcellsbyproducingreactivealkylatingagents
concomitant with depletion of intracellular glutathione. To
investigatethisrelationshipfurther,theeffectof
modulating intracellular glutathione on the toxicity of 1,2-
dibromoethane in freshly isolated hepatocytes was studied.
This report details my findings as related to glutathione
depletion, lipid peroxidation and 1,2-dibromoethane-induced
cell death in freshly isolated rat hepatocytes.66
Materials and Methods
Chemicals:
1,2-Dibromoethane, methionine, N-acetyl-cysteine,
iodoacetamide, butylated hydroxyanisole, ruthenium red, and
William'sE medium were purchased from Sigma Chemical
Company (St.Louis, Mo.).Desferal mesylate was kindly
provided by Ciba-Geigy (Summit, NJ).All other chemicals
were reagent grade or better.
Isolation of Hepatocytes and Modulation of Intracellular
Glutathione Levels:
Hepatocytes were isolated from male Sprague-Dawley rats
(180-200gm) as described (Fariss and Reed, 1987) with slight
modification as noted below.Isolation of hepatocytes as
described by Fariss and Reed (1987) produced hepatocytes
containing approximately14nmolesofglutathioneper
million cells.Viability of hepatocytes directly following
isolation was better than 90% as assessed by trypan blue
exclusion.The substitution of William's E medium (serum
free)for Hank's bicarbonate buffer during collagenase
perfusionandsuspensionofisolatedhepatocytesin
Fischer's medium containing 0.67 mM methionine gave rise to
hepatocytes with elevated levels of glutathione (23 to 45
nmoles per million cells).As above, viability was greater
than 90%.
The term "system-1" will denote throughout this report
the isolation and incubation of hepatocytes in the absence
of sulfur amino acids and "system-2" for the isolation and
incubation in the presence of sulfur amino acids.67
Incubation of Hepatocytes with 1,2-Dibromoethane:
Hepatocytes obtained following the Hank's/collagenase
perfusion were suspended (2.0 X 106 cell per ml) in Fisher's
media containing 2.5 mM calcium, 10 mM 4-((2-hydroxyethyl)-
1-piperazine)ethanesulfonic acid (HEPES) and lacking all
sulfuraminoacids(FarissandReed,1987). Twenty
milliliters of cellsuspension were placed into 50-m1
Florence flasks and 1,2-dibromoethane added directly into
each flask with dimethylsulfoxide as the vehicle (0.1 ml
dimethylsulfoxide per 20 ml of cell suspension).The flasks
were sealed with rubber septums immediately afteraddition.
Cells were then incubated for 6 hours at 37°C in an orbital
shaker. The cellsuspensions wereincubated undera
constant flow of 95% O 5% CO, after the first hour of
incubation.
Hepatocytes isolated following William's E medium/
collagenase perfusion weretreatedasabovewith one
exception;methionine(0.67mM)wasincludedinthe
Fischer's medium.
Addition of Various Agents:
The following agents(0.1ml)were added to the
appropriate flasks after the first hour of incubation with
1,2-dibromoethane.Desferal mesylate (40 gmoles/ ml 20mM
HEPES),ruthenium red(5/moles/ ml20mM HEPES)or
butylated hydroxyanisole (20 gmoles/ml dimethylsulfoxide)
were added to flasks containing 20 ml of cellsuspension to
yield concentrationsof0.2mM,25AM,and0.1mM,
respectively. N-Acetyl-cysteine was added as the dry powder
to the cell suspension yielding a concentration of 10 mM.68
Determination of Intracellular Glutathione and Formation of
Thiobarbituric Acid-reactive Species:
The determination of intracellular glutathione was
performed as described (Fariss and Reed, 1987).However,
iodoacetamide was substituted for iodoacetic acid in the
derivatization of glutathione prior to the addition of
Sanger's reagent.
The amount of thiobarbituric acid-reactive species
presentin0.25mlcellsuspension was determined as
described (Stacey and Klaassen, 1981).Aliquots of sample
were placed into 96-well plates for colorimetric analysis
utilizingamulti-wellplatereader(#EL340,Bio-Tek
Instruments Inc., Winooski, VT).
Determination of Lactate Dehydrogenase Leakage:
Lactate dehydrogenase activity was assayed
spectrophotometrically. An aliquot of medium devoid of
cells was diluted with an equal volume of saline.Ten
microliters of this diluted media was placed into the wells
of a 96-well plate.Two hundred microliters of lactate
dehydrogenase reagent (Beckman Liquid-Stat LD-L reagent,
Beckman Instruments Inc., Brea, CA) was then added and the
increase in absorbance at 340 nm recorded with a multi-well
plate reader.The rate of change of absorbance was compared
with the total lactate dehydrogenase activity present in the
cell suspensions upon initiation of the experiment.Total
lactate dehydrogenase activity was determined as above
following addition of 150 Al of cell suspension to 50 Al of
0.4% Triton X-100, brief sonication (5 seconds) and addition
of 0.4 ml of saline.69
Results
Intracellular glutathione was found to differ markedly
depending upon the isolation procedure and incubation medium
(Figure 10).The isolation and incubation of hepatocytes in
the presence of media containing sulfur amino acids gave
rise to elevated intracellular glutathione at the start of
each experiment with continued elevation during the 6 hours
of incubation to levels four times greater than isolation
and incubation without sulfur amino acids.
The toxicity of 1,2-dibromoethane (100, 200 and 500
AM), as assessed by leakage of lactate dehydrogenase, was
markedly different under conditions of elevated verses
reduced intracellular glutathione (Figure 11).Within 2
hours of exposure to 200 and 500 AM 1,2-dibromoethane,
hepatocytes in system-1 had expressed significant leakage of
lactate dehydrogenase.By 6 hours this leakage amounted to
greater than 75% of total. 1,2-Dibromoethane (100 AM)
exposed cells exhibited significant lactate dehydrogenase
leakage only after 6 hours of incubation.In contrast, 100,
200 and 500 AM 1,2-dibromoethane did not induce significant
lactate dehydrogenase leakage from hepatocytes in system-2
during the course of incubation.
1,2-Dibromoethane induced a dose- and time-dependent
depletion of intracellular glutathione for both system -i and
system-2 hepatocytes (Figure 12).However, the degree of
depletionandsubsequentrepletionweredramatically
differentbetweenthetwosystems. Undersystem-1
conditions, intracellular glutathione was depleted to below
5 nmoles of glutathione per million cells within the fist
hour of incubation.Within 4 and 6 hours of incubation
intracellular glutathione was depleted to below detectable50-
MO.
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Figure 10. Modulation of Intracellular Glutathione in
Isolated Rat Hepatocytes. Intracellular modulation of
glutathione was accomplished by modifying the conditions of
hepatocyteisolationandincubation. Theeffecton
intracellular glutathione of isolation and incubation of
hepatocytes with media lacking sulfur amino acids (squares)
was markedly different from isolation and incubation of
hepatocytesinmediacontainingsulfuraminoacids
(circles).The data represent at least three separate
experiments ± SE.71
Figure 11.1,2-Dibromoethane-induced Lactate Dehydrogenase
Leakage from Isolated Rat Hepatocytes. Panel "A" represents
lactate dehydrogenase leakage from hepatocytes isolated/
incubated in the absence of sulfur amino acids (system-1)
whereas panel "B"represents isolation/incubation in the
presence of sulfur amino acids(system-2). The data
represent at least 3 separate experiments ± SE."*" denotes
that this value is significantly different from control at
this and subsequent time points (P < 0.01).DBE = 1,2-
dibromoethane.a
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Figure 12.1,2-Dibromoethane-induced Depletion of Intra-
cellular Glutathione in Isolated Rat Hepatocytes. This
figure depicts the 1,2-dibromoethane-induced depletion of
intracellular glutathione in hepatocytes under conditions of
isolation/incubationintheabsence(system-1)(A)or
presence (system-2)(B) of sulfur amino acids.The data
represent at least 3 separate experiments ± SE."*" denotes
that this determination is significantly different from
control at this and subsequent time points (P < 0.05)."+"
denotes that the 1,2-dibromoethane-induced depletions were
to levels significantly different than control (P < 0.01).
DBE = 1,2-dibromoethane.U)
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levels (0.5 nmoles per million cells) for 500 and 200 pM
1,2-dibromoethane, respectively. In contrast, under system-
2 conditions, glutathione depletion to less than 5 nmoles of
glutathione per million cells occured only after 500 pM 1,2-
dibromoethane exposure.This took place within the first
hour of incubation but did not persist as the level of
intracellular glutathione increased to more than 7.0 nmoles
per million cells by the second hour of incubation and
remained above 5 nmoles per million cells for the remainder
of the incubation period.1,2-Dibromoethane (200 AM) did
not deplete intracellular glutathione below 10 nmoles of
glutathione per million cells at any time during the
incubations.1,2-dibromoethane (100 AM) exposure gave rise
to a slight depletion of intracellular glutathione within
the first hour of incubation followed by repletion to
control levels by the fourth hour of incubation.
The formation of thiobarbituric acid-reactive species
is indicative of lipid peroxidation.Thiobarbituric acid-
reactive species formation occurred in a dose- and time-
dependent manner following 1,2-dibromoethane exposure of
hepatocytes in system-1 but not system-2 (Figure 13).The
generation of thiobarbituric acid reactive species was
concomitant with the leakage of lactate dehydrogenase.
The effect of various agents on 1,2-dibromoethane-
induced cell injury was assessed.These experiments were
performed with hepatocytes under system-1 conditions.The
agents were added to the cell suspensions following the
first hour of 1,2-dibromoethane treatment.
Butylated hydroxyanisole and desferal mesylate, two
antioxidants with different mechanisms of action, were found
toinhibitbothlactatedehydrogenaseleakageand
thiobarbituric acid-reactive species formation as shown in
figures 14 and 15, respectively.76
Figure13. 1,2-Dibromoethane-inducedFormationof
ThiobarbituricAcid-reactiveSpeciesinIsolatedRat
Hepatocytes. This figure depicts the 1,2-dibromoethane-
induced formation of thiobarbituric acid-reactive species in
hepatocytes under conditions of isolation/incubation in the
absence (A) or presence (B) of sulfur amino acids.The data
represent at least 3 separate experiments ± SE."*" denotes
that this determination is significantly different from
control at this and subsequent time points (P < 0.01).DBE
= 1,2-dibromoethane.Cl)
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Figure 14.The Effect of Butylated Hydroxyanisole on 1,2-
DibromoethaneToxicityinIsolatedRatHepatocytes.
Butylated hydroxyanisole (BHA)(0.1 mM) was added to the
cell suspensions following 1 hour of 1,2-dibromoethane (DBE)
exposure (0.5 mM).11" denotes that this determination and
all subsequent determinations are significantly different
from the control and 1.2-dibromoethane-treated hepatocytes
with butylated hydroxyanisole (P < 0.05). Thiobarbituric
acid-reactive species (TBA-RS).70
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Figure15. The EffectofDesferal Mesylate on1,2-
DibromoethaneToxicityinIsolatedRatHepatocytes.
Desferal mesylate (DESF)(0.2 mM) was added to the cell
suspensions following 1 hour of 1,2-dibromoethane (DBE) (0.5
mM) exposure."*" denotes that this determination and all
subsequent determinations are significantly different from
the control and 1.2-dibromoethane-treated hepatocyteswith
desferal mesylate (P < 0.05).Thiobarbituric acid-reactive
species (TBA-RS).20
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N-Acetyl-cysteine, a source of free thiol and potential
supplier of cysteine for glutathione biosynthesis, reduced
the extent of lactate dehydrogenase leakage from hepatocytes
withoutreducingthiobarbituricacid-reactivespecies
formation (Figure 16). The leakage of lactate dehydrogenase
from 1,2-dibromoethane-treated hepatocytes was reduced by
43,40and10%at2,4and6hoursofincubation,
respectively. Thiobarbituricacid-reactivespecies
formation was not different from control through 4 hours of
incubation and increased to 170% of control by 6 hours of
incubation.
Ruthenium Red, an agent that influences the cellular
transport of calcium, had no effect on lactate dehydrogenase
leakage but was found to lower the thiobarbituric acid-
reactive species formation at 4 and 6 hours of incubation
(Figure 17).Ruthenium red inhibited the formation of
thiobarbituric acid-reactive species by 39 and 38% at 4 and
6 hours of incubation, respectively.83
Figure16. TheEffectofN-Acetyl-cysteineon1,2-
Dibromoethane Toxicity in Isolated Rat Hepatocytes. N-
Acetyl-cysteine (N-acetyl-cys) (10.0 mM) was added to the
cell suspensions following 1 hour of 1,2-dibromoethane (DBE)
(0.5 mM) exposure."*" denotes that this determination is
significantly different from the N-acetyl-cysteine and 1.2-
dibromoethane treated hepatocytes (P < 0.01)."+" denotes
significantly different than control (P < 0.01). "#" denotes
that this value is significantly different than control and
1 , 2-dibromoethane + N-acetyl-cysteine treated hepatocytes (P
< 0.05).Thiobarbituric acid-reactive species (TBA-RS).S
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Figure 17.The Effect of Ruthenium Red on 1,2-Dibromoethane
Toxicity in Isolated Rat Hepatocytes.Ruthenium red (25.0
pM) was added to the cell suspensions following 1 hour of
1,2-dibromoethane (DBE) (0.5mM) exposure."*" denotes that
thisandsubsequentdeterminationsaresignificantly
different from the ruthenium red control (P < 0.01). " +"
denotessignificantlydifferentthan1,2-dibromoethane
treated hepatocytes(P <0.05)at this and subsequent
determinations.Thiobarbituric acid-reactive species (TBA-
RS).2
0
A
O
D
B
E
0
R
u
t
h
e
n
i
u
m
R
e
d
I
I
D
B
E
+
R
u
t
h
e
n
i
u
m
R
e
d
*
5
_
O
C
)
a
s
.
.
v
7
0
4
1
0
I
6
0
4
)
.
.
.
-
.
.
.
.
=
c
o
t
g
5
0
C
t
O
I
C
I
)
0
4
0
c
*
.
)
,
.
.
.
>
%
3
0
_
.
0
0
C
I
8
0
i
2
0
_
B
*
F
i
g
u
r
e
1
7
.
'
I
0
.
0
1
.
0
2
.
0
3
.
0
4
.
0
5
.
0
T
i
m
e
(
h
o
u
r
)
6
.
0
7
.
0
8
687
Discussion
This investigation has demonstrated that maintenance of
intracellular glutathione to levels above 5.0 nmoles per
million cells protected against 1,2-dibromoethane-induced
lipidperoxidationandcelldeath. Freshlyisolated
hepatocytes were shown in the previous chapter to utilize
glutathione extensively in 1, 2-dihaloethane metabolism. 1 , 2-
Dihaloethane induced glutathione depletion and the formation
of at least three glutathione-containing metabolites.The
formation of a reactive sulfur half-mustard, S-(2-halo-
ethyl)glutathione, was thought responsible for most of the
glutathione depletion, metabolite formation, and covalent
binding of 1,2-dibromoethane to hepatocyte protein.
S-(2-Chloroethyl)glutathione, a representative
glutathione sulfur half-mustard, was shown to be an active
alkylatingagenttowardavarietyofmodelcompounds
including glutathione (Jean and Reed, 1989). Therefore, the
maintenanceofanadequateamountofintracellular
glutathione may haveafforded protection against1,2-
dibromoethane-derivedglutathionesulfurhalf-mustard
alkylationofcellular macromolecules. However,1,2-
dibromoethanemetabolismmaygiverisetoreactive
metabolites other than the glutathione sulfur half-mustard.
Increasedintracellularglutathionemayhaveprovided
protection against these metabolites as well.
The depletion of intracellular glutathione by 1,2-
dihaloethanes mayitselfresultinthe generationof
injurious oxidative stress.Such a situation could arise by
virtue of reducing the cell's capacity to deal adequately
with the endogenous generation of reactive oxygen species.
It has been estimated that 2-5% of the mitochondrial88
consumption of oxygen results in the formation of hydrogen
peroxide(Chance et al.,1979). Glutathione and the
glutathione redox cycle represent a major cellular defense
system against hydrogen peroxide as well as other organic
peroxides (Reed, 1986).Glutathione depletion to levels
below 10-20% of normal may severely reduce the cell's
ability to defend against oxidative injury (Younges and
Siegers, 1981).
1,2-Dibromoethane-induced glutathione depletion
preceded theformation of thiobarbituric acid-reactive
species, an indicator of lipid peroxidation.In agreement
with the above proposal, the maintenance of intracellular
glutathione at levels above 5 nmoles per million cells
(approximately 14% of normal, assuming a normal glutathione
content of 35 nmoles per million cells) was associated with
decreased lipid peroxidation.In addition, the maintenance
of intracellular glutathione inhibited lactate dehydrogenase
leakage, ie. cell death.
Cell death and lipidperoxidationoccurred
concomitantlyin1,2-dibromoethane-treatedhepatocytes
following glutathione depletion.This observation led to
the investigation of the role of lipid peroxidation in 1,2-
dibromoethane-induced cell death.
The antioxidant, butylated hydroxyanisole, and the iron
chelator,desferalmesylate,inhibitedbothlipid
peroxidation and cell death. An observation suggesting that
lipid peroxidation may be principally involved in 1,2-
dibromoethane-induced cell death.The effect of desferal
mesylate would indicate the importance of iron in the lipid
peroxidation process.
N-Acetyl-cysteine (10 mM) reduced lactate
dehydrogenase leakage through 4 hours of incubation without
a reduction in lipid peroxidation.This effect was not89
related to increased intracellular glutathione as N-acetyl-
cysteine did not promote glutathione synthesis.Therefore
its effects were most likely related to providing the cells
with additional free thiol.The additional free thiol may
have protected critical protein thiols from modification by
reactive 1,2-dibromoethane metabolites or products of lipid
peroxidation.
Ruthenium red (25 pM) did not protect against 1,2-
dibromoethane cell death but did reduce the amount of lipid
peroxidation.This compound has been shown to inhibit the
uptakeofcalcium byisolated mitochondria(Reedand
Bygrave, 1974), to reduce plasma membrane Ca-ATPase activity
(Missiaen et al., 1990) and inhibit the release of calcium
from sarcoplasmic reticulum (Kanmura et al., 1989).The
results with ruthenium red would suggest that calcium fluxes
responsive to ruthenium red modulation are not involved to
any great extent in 1,2-dibromoethane-induced toxicity in
isolatedrathepatocytesundertheseexperimental
conditions.
Theeffectofthesevariousagentsonlipid
peroxidation and cell death suggest that lipid peroxidation
can play a significant role in the development of 1,2-
dibromoethane-induced cell death in this model system.
Whether lipid peroxidation is due to extensive glutathione
depletion or the result of other cellular injury involving
the interaction of 1,2-dibromoethane reactive metabolites
with other cellular constituents is not known.90
ALPHA-NAPHTHYLISOTHIOCYANATE TOXICITY AND GLUTATHIONE
DEPLETION IN FRESHLY ISOLATED RAT HEPATOCYTES.
Introduction
Cholestasis may occur in humans as a side effect of
specific drugs or viral infections.This dysfunction may
result from a variety of circumstances ranging from the
intra- and extrahepatic obstruction of bile ducts to the
inhibition of bile acid formation within hepatocytes.Our
understanding of drug-induced cholestasis in humans is very
incomplete due to the complex nature of bile formation, bile
flow, and the infrequency of drug-induced cholestasis in
humans.
alpha-Naphthylisothiocyanate has been used extensively
to induce intrahepatic cholestasis in animals as a model
system for study. alpha-Naphthylisothiocyanate-induced
cholestasisisassociatedwithavarietyofeffects
including hyperbilirubinemia, serum elevations of bile acids
and marker enzymes indicative of liver injury, inflammation
of portal tracts, necrosis of interlobular bile ducts and
focal necrosis of hepatocytes (Plaa andPriestly, 1977).
The mechanism(s) responsible for these effects is unknown.
However, metabolism of alpha-naphthylisothiocyanate to a
toxic species by the mixed-function oxidase system has been
suggested (Roberts and Plaa, 1965).
Induction of mixed-function oxidase activity was shown
to enhance alpha-naphthylisothiocyanate liver injury whereas
the inhibition of mixed-function oxidase activity diminished
alpha-naphthylisothiocyanate liver injury (Roberts and Plaa,
1965).These observations only offer an indirect91
associationlinking mixed-function oxidaseactivity to
alpha-naphthylisothiocyanate toxicity. A toxicalpha-
naphthylisothiocyanate metabolite has yet to be identified
or its mechanism of action defined. Therefore,it is
altogether possible that mixed-function oxidase metabolism
may have little to do with alpha-naphthylisothiocyanate-
induced liver injury.
The agents used to modulate mixed-function oxidase
activity are also known to influence the activity of other
enzyme systems.Recently, investigators (Dahm and Roth,
1991) have recognized that the agents used to induce mixed-
function oxidase activity have been shown toincrease
hepatic glutathione content and glutathione transferase
activity.In addition, the inhibitors of mixed-function
oxidase activity are known to decrease hepatic glutathione
contentandglutathionetransferaseactivity. The
modulationofglutathioneandglutathionetransferase
activity may have contributed to the observed potentiation
and/or inhibition of alpha-naphthylisothiocyanate toxicity.
It is interesting that the effects of the "modulating"
agents suggest that glutathione and glutathione transferase
function to promote alpha-naphthylisothiocyanate toxicity.
Dahm and Roth (1991) recently reported that modulation
of hepatic nonprotein thiol (presumably glutathione) greatly
influenced alpha-naphthylisothiocyanate liver injury.They
observed that depletion of hepatic nonprotein thiol with
buthionine sulfoximine, diethyl maleate or phorone protected
against alpha-naphthylisothiocyanate-induced liver injury.
In addition,the repletion of hepatic nonprotein thiol
content was coincident with the development of alpha-
naphthylisothiocyanate liver injury.These observations
lend support to the hypothesis that nonprotein thiols are
involved in the development of alpha-naphthylisothiocyanate-92
induced liver injury.
In an effort to better define the role of glutathione
in alpha-naphthylisothiocyanate-induced liver injury its
effectonintracellular glutahtioneand toxicity were
examinedinfreshlyisolatedrathepatocytes. The
spontaneous, nonenzymatic reaction of alpha-naphthyliso-
thiocyanate with glutathione was also studied.The results
presented herein have recently been presented elsewhere
(Carpenter-Deyo et al., 1991).93
Materials and Methods
Chemicals:
Allchemicals were purchasedfromSigma Chemical
Company(St.Louis,MO). SolventswereHPLCgrade
(OmniSolv,EM Science,Gibbstown,NJ)except dimethyl-
sulfoxide (DMSO) (AR grade, Mallinckrodt Inc., Paris, KT)
and deuterated NMR solvents which were purchased from
Aldrich Chemical Company (Milwaukee, WI).
Synthesis of
conjugate:
30 mg of alpha-naphthylisothiocyanate (0.16 mM) was
dissolved in 1.0 ml of acetonitrile.350 mg of glutathione
dissolved in 4.0 ml of 0.10 M TRIS buffer, pH = 7.0, was
added dropwise to the solution of alpha-naphthylisothio-
cyanate over a 2 minute period.After stirring at room
temperature for 5 minutes, the pH was adjusted to < 4 with
the addition of 1.0 ml glacial acetic acid.The glutathione
conjugatewasthenpurifiedviahigh-pressureliquid
chromatography (HPLC) utilizing a 9.6 mm x 300 mm reverse-
phase C18 column (Custom LC, Houston, TX).A mobile phase
of 20% acetonitrile, 0.1% acetic acid was used to elute the
material from the column into a collection flask immersed in
liquidnitrogen. Themobilephasewasremovedby
lyophilization.Post column detection at 308 nm allowed
detection of the glutathione conjugate.The glutathione
conjugate was stored at -80°C after lyophilization.
Theidentityoftheglutathione-alpha-naphthyl-
isothiocyanateconjugatewasverifiedbyFastAtom
Bombardment MassSpectroscopy(FAB-MS)and thinlayer
chromatography (TLC).FAB-MS analysis was performed with a
Glutathione-alpha-naphthylisothiocyanate94
Kratos MS5OTC RF mass spectrometer, a 7 KV xenon beam for
ionization and a glycerol matrix.TLC analysis involved
spotting sample onto silica gel TLC plates(Analtech,
Newark, DE) and development with isopropyl
alcohol/water/acetic acid (85/14/1).Rf value comparisons
were made between glutathione, alpha-naphthylisothiocyanate
and the glutathione-alpha-naphthylisothiocyanate conjugate
as observed with UV light or ninhydrin reaction.Proton
magnetic resonanceanalysis wasattempted withlittle
success due to the conjugates instability and low solubility
in aqueous solutions.However, the spectra obtained did
give an indication that both alpha-naphthylisothiocyanate
and glutathione were present in the sample.
Isolation and Treatment of Hepatocytes:
Hepatocytes were isolated from male Sprague-Dawley rats
(180-200gm)according to Farissand Reed(1987)and
suspended (2.0 x 106 cells per ml) in a modified Fischer's
media (lacking sulfur amino acids) containing 2.5 mM calcium
and10mM4-((2-hydroxyethyl)-piperazine)ethanesulfonic
acid.Initial viability was greater than 90% as assessed by
trypan blue exclusion.
Aliquots of cell suspension (15 ml) were treated with
vehicle (DMSO, 100 41), alpha-naphthylisothiocyanate, or the
glutathione-alpha-naphthylisothiocyanate conjugate.Cells
were then incubated at 37 °C under an atmosphere of 95% 0
5% CO2 for up to 4 hours.Aliquots of cell suspension were
taken prior to and at various times after addition of agents
to assess lactate dehydrogenase leakage,thiobarbituric
acid-reactive species formation, intra- and extracellular
glutathione content.
To determineifisolated hepatocytes produceand
excrete the glutathione-alpha-naphthylisothiocyanate95
conjugate, aliquots of exctracellular media were analyzed
following exposure.Hepatocytes, isolated as above were
resuspended to 5.0x106 cells per ml in the modified
Fischer's media were treated with 1.0 mM alpha-naphthyl-
isothiocyanate.At various times 1.0 ml aliquots were
taken, centrifuged at 12,000 rpm to pellet the cells and 0.5
ml of media immediately frozen with liquid nitrogen.These
samples were lyophilized and subjected to HPLC analysis to
test for the presence of glutathione-alpha-naphthylisothio-
cyanate conjugate.
HPLC Analysis:
HPLC analysisinvolved dissolving thelyophilized
material in 0.2 ml of 35% acetonitrile containing either 1.0
M sodium acetate (pH = 4.0) or 0.05 M sodium phosphate (pH
= 8.0), and centrifugation to remove insoluble material
prior to HPLC analysis.Aliquots of sample were injected
onto a reverse phase C18 column (Custom LC, Houston, TX) 4.6
mm X 250 mm.The elution of material from the column was
accomplishedbylinearlyincreasingthecontentof
acetonitrile in 0.05 M sodium acetate (pH = 4.0) from 10% to
70% over a 15 minute period.Post column detection was made
at 308 nm with a SpectroFlow 757 detector.
Biochemical Analysis:
The separation of viable cells from non-viable cells
was achieved as described by Fariss et al. (1985) and the
quantification of extra- and intracellular glutathione and
glutathione disulfideas described by Farissand Reed
(1987). Lactate dehydrogenase leakage from the hepatocytes
was determined spectrophotometrically as described by Fariss
et al. (1985) with the use of a Kontron spectrophotometer
(UVikon 810).Thiobarbituric acid-reactive species96
formation was performed as described by Stacey and Klaassen
(1981).
Statistical Analysis:
Data were analyzed using a one-way analysis of variance
(ANOVA) program from Statview (Brainpower, INC., Calabasas,
CA) and means were compared by a Dunnett's test. P < 0.05
was chosen as the level of significance.97
Results
Freshly isolated hepatocytes were incubated with 0, 50
100 and 500 pM alpha-naphthylisothiocyanate for up to 4
hours.The leakage of lactate dehydrogenase from the cells
was used to assess toxicity.Lactate dehydrogenase leakage
did not differ from controls except for 500 pM alpha-
naphthylisothiocyanate exposure as shown in figure 18.The
increase in lactate dehydrogenase leakage began after 2
hours of incubation and increased to almost 100% by 4 hours.
Glutathione depletion was observed for all of the
alpha-naphthylisothiocyanate exposures but varied in the
extentandtimeofdepletion(Figure19). alpha-
Naphthylisothiocyanate(50pM)decreasedintracellular
glutathione to 60% of control by1hour of incubation
followed by total repletion by 4.0 hours.alpha-Naphthyl-
isothiocyanate (100 pM) decreased intracellular glutathione
to 35% of control by 1.0 hour and remained at this level for
the rest of the incubation.alpha-Naphthylisothiocyanate
(500 pM) mimicked the 100 pM treatment for the first 2.0
hours of incubation and then the intracellular glutathione
content dropped to levels below the limit of detection (0.5
nmoles per million cells) by 4 hours.
Thealpha-naphthylisothiocyanate-inducedlossof
intracellularglutathionewasconcomitantwiththe
appearance of extracellular glutathione and glutathione
disulfide. Figure20depictsthetime-dependent
accumulation of glutathione equivalents in the extracellular
medium.Unlike the depletion of intracellular glutathione
theappearanceofglutathioneequivalencesinthe
extracellular medium showed only a slight dependence on
dose.Each of the exposures caused the accumulation of98
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Figure 18.alpha-Naphthylisothiocyanate-induced Release of
LactateDehydrogenasefromIsolatedRatHepatocytes.
Hepatocytes in suspension were treated with 0, 50, 100 and
500 pM alpha-naphthylisothiocyanate (dimethylsulfoxide as
vehicle) for up to four hours and analyzed as described in
the "Materials and Methods section.Lactate dehydrogenase
leakage is expresses as the % of total lactate dehydrogenase
releasible by 0.4%Triton X-100 at time zero. Data
representthe mean ± SEofatleastthreeseparate
experiments.(*)denotessignificantlydifferentfrom
control (p < 0.05).140
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Figure 19.alpha-Naphthylisothiocyanate-induced Depletion
of Intracellular Glutathione from Isolated Rat Hepatocytes.
Hepatocytes in suspension were treated with 0, 50, 100 and
500 pM alpha-naphthylisothiocyanate (dimethylsulfoxide as
vehicle) for up to four hours and analyzed as described in
the"MaterialsandMethodssection. Intracellular
glutathione is expressed as % of the control for that time
point.Data represent the mean ± SE of at least three
separate experiments.(*) denotes significantly different
from control at this time point and all subsequent time
points (p < 0.05).(+) denotes significantly different from
control at this time point.60
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Figure 20. alpha-Naphthylisothiocyanate-induced
Extracellular Accumulation of Glutathione.Hepatocytes in
suspension were treated with 0, 50, 100 and 500 pM alpha-
naphthylisothiocyanate (dimethylsulfoxide as vehicle) for up
to four hours and analyzed as described in the "Materials
and Methods section.Values represent the sum total of
glutathione as the reduced form and that amount present as
glutathione disulfide.Data represent the mean ± SE of at
least three separate experiments. (*) denotes that treatment
with alpha-naphthylisothiocyanate resulted in the
extracellularaccumulationofglutathionetolevels
significantly greater than the control (p < 0.05).101
extracellular glutathione to approximately 50-55 pM in 2
hours with no significant changes thereafter.
The interaction of alpha-naphthylisothiocyanate with
glutathione was assessed via HPLC.HPLC analysis of alpha-
naphthylisothiocyanate in 35% acetonitrile, 50 mM potassium
phosphate buffer, pH = 7.5 gave rise to a single peak in the
chromatogram representing alpha-naphthylisothiocyanate. The
addition of glutathione to this solution resulted in the
reduction in size of the alpha-naphthylisothiocyanate peak
and the appearance of new peak in the chromatogram.This
new peak elutes from the reverse phase column well after
glutathione but before alpha-naphthylisothiocyanate.The
simplicity of the reaction mixture and the retention time
characteristics suggest that this new peak represents the
formationofaglutathione-alpha-naphthylisothiocyanate
conjugate.FAB-MS analysis of this material supports the
contention thatthis materialisaglutathione-alpha-
naphthylisothiocyanate conjugate (Figure 21).In addition,
the mass spectrum contains evidence that the material is a
glutathione S-conjugate.This glutathione S-conjugate was
further characterized by Dr. Dan Marchand and found to be
stableinacidandunstableinneutraloralkaline
solutions.
The presence of the glutathione-alpha-naphthylisothio-
cyanate conjugate in the extracellular media of alpha-
naphthylisothiocyanate treated cells was assessed via HPLC.
Aliquots of cell suspension were taken at various times
following exposure to alpha-naphthylisothiocyanate.HPLC
analysisofthecell-freemediumindicatedthatthe
glutathione S-conjugate was present (Figure 22).The HPLC
chromatogram of medium from exposed cells contained four
distinct peaks not present in control cells.One of these
peaks coelutes with the purified glutathione-alpha-102
Figure 21.Fast Atom Bombardment Mass Spectrum of the
Glutathione-alpha-naphthylisothiocyanate Conjugate. The
conjugate was dissolved into a glycerol matrix just prior to
analysisasdescribedinthe"Materialsand Methods"
section. Themolecular ion peak a m/Z 491 corresponds to
that predicted for the molecular ion of the glutathione S-
conjugate of alpha-naphthylisothiocyanate..11
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Figure 22.HPLC Analysis for the Presence of Glutathione S-
conjugate of alpha-Naphthylisothiocyanate in Suspensions of
Treated Hepatocytes.Hepatocytes (5.0 x 106 cells per ml)
were treated with 1.0 mM alpha-naphthylisothiocyanate for
two hours and aliquots taken and analyzed at various times
as describedinthe"materialsand"Methods"section.
Samplepreparationmaximizingthestabilityofthe
glutathioneS-conjugateallowedforitsdetection
(chromatogram "A", arrow indicates peak assigned to the
conjugate) whereas sample preparation known to destroy the
conjugateresultedindisappearanceofthispeak
(chromatogram "B").The asterisks denote peaks not present
in controls.105
naphthylisothiocyanate conjugateand exhibits thesame
spectral characteristics and alkaline instability.These
data suggest that this peak represents the same glutathione-
alpha-naphthylisothiocyanate conjugate identified in the
simple reaction mixture.
Freshly isolated hepatocytes were treated with 0, 100
and 500 pM glutathione-alpha-naphthylisothiocyanate
conjugate for 4 hours just as was done for alpha-naphthyl-
isothiocyanate.The effects on intracellular glutathione
and leakage of lactate dehydrogenase are depicted in figures
23 and 24.The depletion of intracellular glutathione and
lactate dehydrogenase leakage were almost identical to that
observed for exposure to the same concentrations of alpha-
naphthylisothiocyanate.120
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Figure 23.Effect of the Glutathione S-conjugate of alpha-
NaphthylisothiocyanateonIntracellularGlutathionein
Isolated Rat Hepatocytes. Hepatocytes were treated with the
glutathione S-conjugate of alpha-naphthylisothiocyanate (0,
100 or 500 gM) and analyzed as described in the "Materials
and Methods" section.The data represent the mean ± SE for
atleastthreeseparateexperiments. (*)denote
significantly different than control at this time point and
all subsequent time points (p < 0.05)..5.1
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Figure 24.Effect of the Glutathione S-conjugate of alpha-
Naphthylisothiocyanate ontheLeakage ofLactate
Dehydrogenase from Isolated Rat Hepatocytes.Hepatocytes
were treated with the glutathione S-conjugate of alpha-
naphthylisothiocyanate (0, 100 or 500 2M) and analyzed as
described in the "Materials and Methods" section.The data
represent the mean+SEfor atleast three separate
experiments. (*) denote significantly different than control
at this time point andall subsequent time points (p <
0.05).108
Discussion
This investigation has demonstrated that exposure of
freshly isolated hepatocytes to alpha-naphthylisothiocyanate
produces a dose- and time-dependent depletion of intra-
cellular glutathione.That 500 AM alpha-naphthylisothio-
cyanate was toxic to the cells within 4 hours of exposure
and that toxicity was associated with the depletion of
glutathionetolevelsbelow30%ofcontrol. Alpha-
naphthylisothiocyanate was found to react with glutathione
to form a glutathione S-conjugate.This conjugation was
reversible and the conjugate found to be unstable in neutral
solutions. The presence of this glutathione S-conjugatewas
observed in cell suspensions following treatment with alpha-
naphthylisothiocyanate. TheglutathioneS-conjugate
exhibited the same dose- and time-dependent depletion of
intracellular glutathione and cellular toxicity as observed
for alpha-naphthylisothiocyanate.
Thereactionofalpha-naphthylisothiocyanatewith
glutathione was not unexpected.As a functional group, the
isothiocyanatesareknowntobeveryreactivewith
nucleophiles, particularlysulfhydrylsandamines.
Dithiocarbamates, the product of sulfhydryl conjugation with
isothiocyanates,havebeenshowntobeunstableand
dissociatetogivebackthethiolandisothiocyanate
(Drobnica et al., 1977). Studies with benzyl isothiocyanate
have shown that its conjugation with glutathione may be
spontaneous or catalyzed by the glutathione transferases
(Brusewitz et al.,1977). The conjugation of alpha-
naphthylisothiocyanate with glutathione and the instability
of the conjugate are characteristic of both isothiocyantes
and their conjugates (Drobnica et al., 1977).109
The depletion of intracellular glutathione following
exposure of isolated hepatocytes to alpha-naphthylisothio-
cyanateandtheappearanceofglutathioneinthe
extracellular medium may best be explained as the result of
a cyclic process.This process would involve passive
diffusion of alpha-naphthylisothiocyanate into the cells,
conjugation with glutathione, excretion of the glutathione
S-conjugate into the medium via specific transport processes
for glutathione conjugates, dissociation of the conjugate
giving glutathione and alpha-naphthylisothiocyanate and
passive diffusion of alpha-naphthylisothiocyanate back into
thecelltobeginanothercycle. Inthismanner
intracellular glutathionecan betransportedintothe
extracellular medium. The chemical characteristics of
isothiocyanates and their conjugates as well as the presence
of glutathione transport processes are in support of such a
cycle.
According to this proposal,the cycling of alpha-
naphthylisothiocyanate should lead to the total depletion of
intracellular glutathione.However, total depletion of
intracellular glutathione did not occur except for the
highest dose of alpha-naphthylisothiocyanate. Depletion was
associated with the loss of plasma membrane integrity, as
indicated by the increased lactate dehydrogenase leakage.
One possible explanation for a limit on glutathione
depletion relates to the accumulation of glutathione in the
medium.The accumulation of glutathione or glutathione
conjugates in the medium could potentially inhibit further
excretionofglutathioneconjugates,onceacritical
extracellular concentration is reached.This would appear
to be approximately 50-55 gM.The concentration reached by
all three of the alpha-naphthylisothiocyanate treatments.
There is also the possibility that metabolism of alpha-110
naphthylisothiocyanatetoametabolitethatnolonger
participates in the cycle may contributing to the limited
accumulation of glutathione in the medium.The metabolism
of alpha-naphthylisothiocyanate by liver microsomes has been
demonstrated (Roberts, 1973).In addition, HPLC analysis of
the media from treated cells revealed the presence of
material not present in the control media.The unidentified
material exhibited absorbance characteristics associated
withalpha-naphthylisothiocyanateandaremostlikely
metabolites of alpha-naphthylisothiocyanate that do not
participate in the proposed cycle.
Toxicity,asassessed by theleakageoflactate
dehydrogenasefromhepatocytes,developedonlyafter
exposure to 500 gM alpha-naphthylisothiocyanate and more
than two hours of incubation.Glutathione depletion to as
low as 30% of control was not toxic and lipid peroxidation
didnotappeartoplayaroleasanincreasein
thiobarbituric acid-reactive species was not observed.The
leakage of lactate dehydrogenase from cells is indicative of
substantial membrane damage and increased permeability. The
depletion of intracellular glutathione between 2 and 4 hours
of incubation occurred in concert with the increase in
lactatedehydrogenaseleakage. Suggestingthatthis
depletion is a function of membrane permeability and not due
to the formation of glutathione conjugates. The data
suggest further that 500 gM alpha-naphthylisothiocyanate was
sufficienttooverwhelmthecellsdefensemechanisms
allowing the toxic species to disrupt the cells ability to
maintain membrane integrity.However, the nature of the
toxicspeciesisunknown,butmayhavebeenalpha-
naphthylisothiocyanate itself, a metabolite or both.
Administrationofalpha-naphthylisothiocyanateto
laboratory animals can result in liver injury marked by111
cholestasis, hyperbilirubinemia, necrosis of intralobular
bile duct epithelium and focal necrosis of hepatocytes (Plaa
and Priestly,1977).The mechanism(s) by which alpha-
naphthylisothiocyanate produces these effects is unknown.
Inducers and inhibitors of mixed-function oxidase activity
have been shown to potentiate or diminish alpha-naphthyl-
isothiocyanate toxicity, respectively (Plaa and Priestly,
1976, El-Hawari and Plaa, 1979). These observations suggest
that mixed-function oxidase metabolism to a toxic species is
responsible.However, a different interpretation has been
made suggesting that glutathione may be more important than
mixed-function oxidase activity(Dahm and Roth,1919).
Recent investigations have demonstrated that depletion of
hepatic glutathione protects against alpha-naphthyliso-
thiocyanate-induced liver injury (Dahm and Roth, 1991).
This may be a direct effect on the excretion of alpha-
naphthylisothiocyanate as a reversible glutathione conjugate
into the bile.In this way influencing the amount of alpha-
naphthylisothiocyanate reaching the bile ductule epithelium.
Therelationshipbetweenalpha-naphthylisothiocyanate
conjugation, metabolism and transport at the cellular level
is depicted in figure 25.
There is much to be learned before we will fully
understand how alpha-naphthylisothiocyanate elicits its
characteristic liver injury.The results obtained with
isolated hepatocytes provide strong support for a potential
role for glutathione conjugation and selective transport of
alpha-naphthylisothiocyanateinalpha-naphthylisiothio-
cyanate-induced liver injury.PigOre25.
WithiPtheZi
GS-NTP
OvervieWofPropos0
vet-.
a/phe-
gloteth.to
.421012e-Sinusoid
ANIT
Hepatocyte
11
Bile Interlobular Bile Ductule Epithelium
Canaliculi Bile duct
ANIT 411-------- ANITII---ANIT___.....Metabolite(s)
iiG9-I GSHil Ily
Metabolite(s) GS-ANIT-4
GS-ANIT4------GS-ANIT--0. Toxicity \V/
Toxicity
Figure25.114
SUMMARY AND FUTURE DIRECTIONS
Observations:
Theinvestigationsdescribedinthisthesishave
provided valuable data and observations that are best
summarized as follows.
S-(2-Chloroethyl)glutathione and S-(2-chloroethyl)-L-
cysteinearedirect-actingalkylatingagentstoward
functional groups common to protein and nucleic acids with
particularly high reactivity toward free sulfhydryl groups.
1,2-Dihaloethane-inducedglutathionedepletionin
isolated rat hepatocytes is the result of its utilization in
1,2-dihaloethane metabolism.The amount and variety of
glutathione-containing metabolites formed suggests that
glutathione sulfur half-mustard formation is responsible for
themajorityofthe1,2-dibromoethaneand1-bromo-2-
chloroethane-induced glutathione depletion.
The development of 1,2-dibromoethane-induced toxicity
inisolatedrathepatocytescanbeblockedbythe
maintenance of a relatively low amount of intracellular
glutathione. Hepatocytesexperienceextensivelipid
peroxidationconcomitantwithcelldeathfollowing
glutathione depletion.Lipid peroxidation is much involved
in the development of cell death in this model system as
indicated bytheeffectsofbutylated hydroxyanisole,
desferal mesylate and N-acetyl-cysteine. However,the
effects of ruthenium red suggest that lipid peroxidation may
not be directly responsible for the 1,2-dibromoethane-
induced cell death.
alpha-Naphthylisothiocyanate readily conjugates with
glutathione to form a reversible S-conjugate. The depletion
of hepatocellular glutathione following alpha-naphthyliso-115
thiocyanate exposure is a consequence of this reversible
conjugationcoupled totheexportoftheglutathione
conjugate, dissociation and re-uptake of alpha-naphthyl-
isothiocyanate into the hepatocyte.This cyclic process
results in the net transport of glutathione out of the
hepatocyte.
Significance:
It was well established in the literature, prior to
initiating my investigations, that two principle metabolic
pathways were responsible for 1,2-dihaloethane metabolism.
That, in vivo, the mixed-function oxidation pathway was
thought responsible for the majority of 1,2-dihaloethane
metabolism but that the direct conjugation with glutathione
was responsible for the DNA alkylation, mutagenicity and
carcinogenicityexhibitedbythesecompounds. The
contribution of either pathway in relationship to target
organtoxicitywasuncertain. Inaddition,protein
alkylation was little studied in contrast to DNA alkylation.
My studies have demonstrated that the glutathione
sulfur half-mustards should give rise to extensive protein
alkylation as compared to the alkylation of DNA.Cysteinyl
thiols being likely targets for alkylation in comparison to
other amino acid functionalities.
The conjugation of glutathione with 1,2-dihaloethanes
was determined to be responsible for much of the 1,2-
dihaloethane-induced depletion of glutathione in isolated
rat hepatocytes. This would give rise to the formation of a
substantialamountofglutathionesulfurhalf-mustard
concomitant with glutathione depletion. In vivo,1,2-
dihaloethane metabolism by the liver in this way may be
responsible for the observed glutathione depletion and
toxicity.116
Theimportanceofglutathione sulfur half-mustard
formation in relationship to covalent binding and target
organ toxicity remains unclear.My initial studies have
demonstrated that 1,2-dibromoethane toxicity in isolated
hepatocytes was dependent upon glutathione depletion and
that lipid peroxidation was important in the expression of
this toxicity.
The effects of alpha-naphthylisothiocyanate have been
welldocumentedwithrespecttothemorphologicand
physiologic conditions manifest in its cholestatic effect
and hepatotoxicity.However, little is known about the
mechanism(s) of action involved in eliciting the cholestatic
and toxic effects.Various roles have been proposed for
metabolites of alpha-naphthylisothiocyanate, tissue
glutathione and polymorphonuclear leukocytesinalpha-
naphthylisothiocyanatecholestasisandtoxicity. Our
studies with isolated rat hepatocytes and glutathione have
clearlydemonstratedthatalpha-naphthylisothiocyanate
conjugatesreversiblywithglutathioneandthatthis
conjugation may lead to glutathione depletion via alpha-
naphthylisothiocyanate cycling.In vivo, this process any
giverisetothetargetedaccumulationofalpha-
naphthylisothiocyanateintothebileasareversible
glutathione conjugate.Resulting in the specific exposure
of bile canalicular membranes and bile ductule epithelial
cells, possibly accounting for some of the characteristic
features in alpha-naphthylisothiocyanate-induced
cholestasis and toxicity.
Recommendations for Future Research:
Based upon the results of my research and what is
presently known about 1,2-dihaloethane toxicity,I would
recommend that future research emphasize 1,2-dihaloethane117
protein alkylation. Specifically, the identification of the
alkylatingspecies,sitesofalkylation,identityof
alkylated proteins and assessment of the importance of
alkylation to protein structure and function.It is likely
thatthesedatawillbeofparamountimportancein
developing an understanding of the underlying mechanism of
1,2-dihaloethane toxicity.
Inregardstoalpha-naphthylisothiocyanate,the
investigation of intra-hepatic glutathione homeostasis in
relationship to the distributionofalpha-naphthyliso-
thiocyanate should merit attention based on our results.
The determination of the susceptibility of isolated intra-
hepatic bile ductule epithelial cells would also be of
interest.In addition, metabolites of alpha-naphthyliso-
thiocyanatehave been observed butnotidentifiedor
characterized for their potential toxicologic effects.
For both 1,2-dihaloethanes and alpha-naphthylisothio-
cyanate there is a real need to more fully characterize the
biochemical and morphologic changes within cells associated
with their exposures. This would serve best in establishing
the cause and effect relationship that is all important in
understanding chemical-induced toxicity.In addition, this
would greatly aid in determining specific sites of action
leading to elucidation of the chemicals mechanism of action
pertinent to the development of the toxic response.118
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